Preview
Full Doc
 | 2002 |
Technology License Agreement (H2ONow)
Technology License Agreement (H2ONow) (20K)
Doc #230484: Click preview link for longer preview.
 Cardinal Minerals Inc
*
EX-10 8 sunh2tech.htm 10.17 TECHNOLOGY LICENSE AGREEMENT
TECHNOLOGY LICENSE AGREEMENT (H2ONOW)
THIS AGREEMENT made the 26th day of November, 2001.
BETWEEN:
Melvin L. Prueitt, an individual having an address at 161 Cascabel, Los Alamos, NM 87544
(the "Licensor")
AND:
Sunspring Inc. (SUNS), a Nevada corporation having an address at 112C Longview Drive, Los Alamos, NM 87544
(the "Licensee")
WHEREAS:
1. RECITALS
1.1 Licensor is the owner of certain technology, including:
(a) technology to economically produce desalinated water from seawater or brackish water using solar energy (herein referred to as the "H2ONOW Technology"), for which there is a patent pending, and as further particularized in Schedule "A";
(b) technology similar to the H2ONOW Technology that uses off the shelf solar collectors (herein referred to as the "H2ONOW Modified Technology") as further particularized in Schedule "B";
(c) technology related to the use of a solar dish with a MECH recuperator (herein referred to as the "SDWATER Technology"), and as further particularized in Schedule "C"; and
(d) technology relating to the collection of solar energy during the day and storage thereof for night time use (herein referred to as the "SOLAWATT Technology"), as further particularized in U.S. Patent No. 6,223,743.
1.2 Licensor and Licensee desire to enter into a license for the Licensed Technology (as defined below). Licensee also desires to undertake to develop the Licensed Technology, to maintain the intellectual property rights in the Licensed Technology, and to be kept informed of all new developments available or known to Licensor hereafter that may be potentially relevant to Licensed Technology.
2. DEFINITIONS
As used in this Agreement the following terms shall, unless the context otherwise requires, have the following meanings:
2.1 "Confidential Information" means any information relating to or disclosed in the course of this Agreement which is or should be reasonably understood to be confidential or proprietary. "Confidential Information" does not include information: 1) already lawfully known to the receiving party, 2) disclosed in published materials, 3) generally known to the public, or 4) lawfully obtained from any third party.
2.2 "Field" means the collection and use of solar energy for the production of desalinated water.
2.3 "Licensed Product" means any product or device which incorporates any feature or element of the Licensed Technology.
2.4 "Commencement Date" means the date on the first page of this Agreement.
2.5 "Term" means the period from the Commencement Date to the earlier of: (a) twenty five years from the Commencement Date; or (b) the date this Agreement is terminated pursuant to Article 7 of this Agreement.
2.6 "Licensed Technology" means the following:
(a) the H2ONOW Technology, the H2ONOW Modified Technology, the SDWATER technology, and the SOLAWATT Technology;
(b) Any improvements, enhancements, and additions to any of the technologies listed in paragraph 2.6(a) and modifications and derivations thereto, conceived or reduced to practice by Licensor either before or during the Term; and
(c) Licensor's proprietary techniques and knowledge directly related to the technology listed in paragraph 2.6(a) known by Licensor either before or during the Term.
2.7 "Gross Receipts" means gross receipts from sales or leases of Licensed Products, including spare parts, components and sub-assemblies thereof, after deducting actual allowances for returned or defective goods, less trade discounts, but before cash discounts and sale of potable water.
2.8 "Affiliated Company" means a company: (a) in which Licensee owns at least 50% of the voting shares; (b) which owns at least 50% of the voting shares of Licensee; or (c) in which at least 50% of the shares thereof are owned by Affiliated Companies.
3. LICENSES
3.1 Grant of Licensed Technology. Licensor grants to Licensee during the Term the exclusive right and license throughout the world, to use the Licensed Technology (excluding the SOLAWATT Technology) and to manufacture, have manufactured, use, market, have marketed, sell and have sold Licensed Products.
3.2 Further Grant of Licensed Technology. Licensor grants to Licensee during the Term the exclusive right and license throughout the world, to use the SOLAWATT Technology in the Field. Licensor further grants Licensee during the Term the nonexclusive right and license throughout the world, to use the SOLAWATT Technology outside the Field.
3.3 Sublicenses. The rights in the Licensed Technology granted by Licensor to Licensee include the right to grant sublicenses, subject to the prior written consent of Licensor, such consent not to be unreasonably withheld.
3.4 Modifications and Improvements. Licensor will disclose to Licensee, as soon as reasonably practicable, all modifications, improvements and enhancements to the Licensed Technology.
3.5 Assignment. The licenses granted herein may be assigned in whole or in part by Licensee.
3.6 Exploitation of Licensed Rights. Licensee will make reasonable efforts to exploit the rights granted by this Agreement, with a view to generating royalties for Licensor.
4. REPRESENTATIONS
4.1 Representations by Licensor. Licensor represents that the following representations are true now and will be true with respect to the Licensed Technology.
(a) To the best of his knowledge, Licensor owns the exclusive right, free and clear of all liens, claims and restrictions of third parties, to use the Licensed Technology without infringing upon or otherwise acting adversely to any right or claimed right of others and to bring actions for the infringement of the Licensed Technology.
(b) To the best knowledge of Licensor, there is no pending or threatened claim or litigation against Licensor contesting Licensor's right to the Licensed Technology, nor does there exist any basis for such claim or litigation, nor has Licensor received any notice that any right of Licensor to the Licensed Technology conflicts with the asserted rights to others.
(c) The Technology License Agreement between Licensee and Licensor relating to the H2ONOW Technology has been terminated and is no force and effect.
(d) Licensor has not entered into any other agreements with other parties that would limit the rights granted to Licensee in this Agreement
5. CONFIDENTIALITY
5.1 Confidentiality.
(a) During and after the term of this Agreement, each party will keep confidential and not disclose to its employees, vendors, customers or others all Confidential Information disclosed to it by the other party under this Agreement except that, on a need to know basis, Licensee may disclose Confidential Information to employees, subcontractors, customers or others who have executed confidentiality agreements obligating them to Licensee at least to the same extent that Licensee is obligated to Licensor under this Article.
(b) Licensee will obtain from all prospective sublicensees confidentiality agreements covering information disclosed to them by Licensee. The agreements shall obligate the sublicensees to Licensee with respect to Confidential Information at least to the same extent the Licensee is obligated to Licensor under this Article.
6. ROYALITES
6.1 Licensed Technology. Licensee will pay Licensor (i) a royalty of 1% of Gross Receipts received by Licensee or an Affiliated Company and (ii) a royalty of 0.5% of the revenue received by Licensee from the sale of goods and services, including desalinated water and electricity, produced using the Licensed Technology in plants controlled by Licensee.
6.2 Form of Lease and Sale. Royalties payable under this Article will be paid for each Licensed Product that is leased or sold by or for Licensee or its sublicensees, regardless of whether the Licensed Product is sold or leased alone or incorporated into subassemblies or finished products.
6.3 Accounting Period. The accounting of royalties under this Article will be on the basis of one year periods ending on the anniversary of the Commencement Date, beginning with the one year period ending on the first anniversary of the Commencement Date. Each such one year period is called in this Agreement a "Royalty Period".
6.4 Minimum Royalties. For each Royalty Period indicated below, Licensee will pay Licensor the applicable minimum royalty:
Royalty Period ending on the / Minimum Royalty
1st Anniversary of the Commencement Date $0
2nd Anniversary of the Commencement Date $25,000
3rd Anniversary of the Commencement Date $25,000
4th Anniversary of the Commencement Date $50,000
5th Anniversary of the Commencement Date $75,000
6th Anniversary of the Commencement Date $100,000
Each Anniversary of the commencement Date beginning with the 7th $100,000
6.5 Statements and Payments to Licensor. Within 15 days following the end of each Royalty Period, Licensee will furnish Licensor with a written statement certified by Licensee, of the royalties due to Licensor hereunder for the Royalty Period, setting forth the computation of the royalties. The statement will also include information reasonably necessary to facilitate verification of the royalty calculation and the identification of Licensed Products for which royalties are due. Payment by Licensee will accompany each such statement.
6.6 Books of Account; Examination. Licensee will at all times keep complete, true and correct books of account containing a current record of leases, sales, sublicense royalties, and other data in sufficient detail to enable the royalties payable under this Agreement to be computed and verified. Subject to reasonable confidentiality restrictions and undertakings, Licensee will permit Licensor, Licensor's duly authorized agent, or an independent certified public accountant appointed by Licensor to have access for inspection and make copies of pertinent books of account at reasonable times during business hours.
6.7 Currency. All royalties due hereunder will be paid in United States Dollars. All royalties for a Royalty Period computed in other currency will be converted into United States Dollars at the buying rate for the transfer of such other currencies to United States Dollars on the date of payment, as quoted by The Chase Manhattan Bank, N.A., or other reputable international bank.
6.8 Taxes. In the event any national government imposes any taxes on any part of the payments by Licensee to Licensor required hereunder and requests Licensee to withhold taxes from such payment, Licensee may deduct such taxes from such payments. Tax receipts indicating payments or withholding of taxes on behalf of Licensor will be promptly submitted to Licensor. Licensee will cooperate with Licensor in a determination of the property of imposition of any such tax.
6.9 Exchange Restriction. In the event any national government imposes any exchange restriction applying to payments required under this Agreement, an account in the name of Licensor will be established in a financial institution of Licensor's choice in the country of such national government, and all monies due Licensor will be paid into such account, or, at Licensor's election, payment will be made to any account designated by Licensor that complies with such restriction.
7. TERM OF GRANTS AND TERMINATION
7.1 Termination of Agreement. This Agreement and the License granted pursuant to this Agreement will terminate upon the earliest to occur of the following events:
(a) Written notice by either party to the other party that the other party has committed a substantial breach of this Agreement, specifying such breach, if such breach is not cured within a 90 day period following receipt of such notice.
(b) Cessation of Licensee doing business with the Licensed Technology.
(c) The commencement of proceedings by or against Licensee under the Bankruptcy Code or state insolvency laws.
(d) Written notice by Licensor to Licensee if royalties payable in a Royalty Period by Licensee to Licensor under Article 6 do not equal or exceed the minimum royalty indicated in the applicable Royalty Period, unless Licensee pays Licensor a sum equal to the difference between such minimum royalty and the amount of royalties actually earned for such Royalty Period.
(e) The expiry of the Term.
7.2 License Following Termination. Following any termination of this Agreement other than as a result of breach by either party, Licensee, at its option, will be entitled to a license limited to: (i) all Licensed Products then on hand (whether in the possession of Licensee or its sublicensees, assignees, agents or distributors), (ii) all Licensed Products that Licensee (or such sublicensees, assignees, agents or distributors) can manufacture with materials then on hand that were specifically purchased for the purpose of manufacturing Licensed Products, and (iii) Licensed Products need to fill bona fide orders placed prior to the date of termination.
7.3 Royalty Payments. Licensee's obligation to pay royalties hereunder through the date of any termination of this Agreement will survive termination of this Agreement, and all such royalties will be due and payable within 30 days following such termination accompanied by the statement described in Article 6. After termination, royalties will continue to accrue hereunder upon the sale, lease, or other disposition of Licensed Products or goods and services produced using the Licensed Technology in plants controlled by Licensee.
8. MARKING
8.1 Affixed to Licensed Products. Licensee will affix (or require any sublicensee or assignee of Licensee to affix) to each Licensed Product or to the package containing such Licensed Product or to an insertion slip in the package with each Licensed Product, a legible notice reading: "Licensed under one or more of the following patents", followed by a list of patent numbers applicable to such Licensed Product.
9. INFRINGEMENT
9.1 Who May Sue. Upon learning of any infringement or misappropriation by any third party of any claim of any issued patent included within the Licensed Technology, either party will promptly notify the other party in writing of such infringement or misappropriation, giving details thereof. Licensor and Licensee both will have the option, either alone or jointly, to take such measures as may be required to terminate any infringement or misappropriation. When either party brings an infringement or misappropriation action, the other party may join as plaintiff and, whether or not it joins as a plaintiff, will cooperate and assist in the preparation and prosecution of the action.
9.2 Allocation of Expenses and Damages. In the case of mutual agreement on the institution of an infringement or misappropriation action against a third party, Licensee will bear one-half and Licensor will bear one-half of all expenses, unless one party declines to participate financially in the prosecution of such action, in which case the party declining to participate will be excused from bearing its share of such expenses and will be excluded from any share of the damages, fees, costs and penalties recovered. In the case of mutual agreement on the institution of an infringement or misappropriation action, Licensee will receive one-half and Licensor will receive one-half of all damages, fees, costs and penalties recovered that remain after first reimbursing each of them for any amounts expended in prosecuting such infringement or misappropriation action.
9.3 Defense of Licensed Technology. If any judicial, administrative or other action or proceeding is commenced in which any right purported to be granted to Licensee by this Agreement is challenged or is the subject of investigation, or in which the validity of any patent or patent claim that is part of Licensed Technology is challenged, Licensee (or its assignee), at its own expense, will have the obligation to defend against any such action or proceeding, in its own name or in the name of Licensor, or both. Licensor will cooperate fully in such defense. In each Royalty Period, Licensee may apply up to 50% of Royalties due Licensor in such Royalty Period to pay its attorney fees and other expenses of defense. Royalties applied to such fees and expenses will be included when determining the Minimum Royalty for such Royalty Period.
10. PATENT EXPENSES
10.1 During the Term:
(a) Licensee may, at its option, renew and maintain and pay all costs of renewing and maintaining the patents included in Licensed Technology.
(b) Licensee may cause Licensor to apply in Licensor's name for United States and non-United States patents which Licensee, in its reasonable discretion after consultation with Licensor, determines are necessary to exploit the rights and licenses granted hereunder. The legal expense to Licensor of applying for such patents will be paid by Licensee to Licensor.
11. NOTICES
11.1 Notices. All notices or other communications required by this Agreement will be in writing and will be hand delivered or sent by certified mail, and will be regarded as properly given if sent to the parties or their representatives at the addresses located below:
If to Licensee:
Sunspring Inc. (SUNS) 112 C Longview Drive Los Alamos, New Mexico 87544
If to Licensor:
Melvin L. Prueitt 161 Cascabel Los Alamos, New Mexico 87544
From time to time during the term of this Agreement, the parties may, at their discretion, designate other representatives, addresses or addressees.
12.1 EXPORT COMPLIANCE
12.1 Compliance With Law. At all times during the Term, Licensee and Licensor will comply in all respects with the Export Administration Act of 1979, 50 U.S.C. paragraph 2401, et seq., the Arms Export Control Act, both as from time to time amended, with regulations promulgated under either, and with administrative acts pursuant to either, and with other applicable statutes and regulations of the United States
13. BINDING EFFECT
13.1 Writing Required. This Agreement constitutes the complete agreement of the parties and cannot be modified except in writing signed by the parties. This Agreement shall bind, and inure to the benefit of, each of the parties and their personal representatives, successors in interest and any approved assigns of Licensee. This Agreement and all amendments hereto shall be governed by and construed and enforced in accordance with the laws of the State of New Mexico, except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent was granted.
14. SURVIVAL
14.1 Survival. The provisions set forth in Articles 4, 5, 7, 8 and Articles 12 through 16 will survive the termination of any license granted hereunder and survive the termination of this Agreement.
15. COUNTERPARTS
15.1 Counterparts. This Agreement may be executed by facsimile and in several counterparts, each of which shall be deemed to be an original and all of which shall together constitute one and the same instrument.
16. ARBITRATION
16.1 Agreement to Arbitrate. All disputes between Licensee and Licensor arising under this Agreement shall be resolved by binding arbitration in Albuquerque, New Mexico, pursuant to the Commercial Arbitration Rules of the American Arbitration Association and the then current New Mexico Uniform Arbitration Act, and judgment upon the award may be entered in any court having jurisdiction.
DATED: Nov. 26, 2001
LICENSOR:
/s/ Melvin L. Prueitt MELVIN L. PRUEITT
LICENSEE:
SUNSPRING INC. (SUNS) a Nevada Corporation
By: Melvin L. Prueitt Its: President
SCHEDULE "A"
H20NOW Technology
(not attached)
230484
|
Chase Manhattan
As referenced in this Technology License Agreement (H2ONow):
Chase Manhattan Bank, – the buying rate for the transfer of such other currencies to United States Dollars on the date of payment, as quoted by The Chase Manhattan Bank, N.A., or other reputable international bank.
6.8 Taxes. In the event any national government imposes any taxes on any part _____________
dt 102342
;
| Melvin L. Prueitt;
Sunspring Inc.
|
Preview
Full Doc
 | 2002 |
Technology License Agreement
Technology License Agreement (19K)
Doc #339753: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
TECHNOLOGY LICENSE AGREEMENT (this "Technology License Agreement"), dated as of January 1, 2002, by and among AirGate PCS, Inc., a Delaware corporation ("Parent"), AirGate Service Company, Inc., a Delaware corporation ("ASC"), AGW Leasing Company, Inc., a Delaware corporation ("AGWL"), AirGate Network Services, LLC, a Delaware limited liability company ("ANS"), iPCS Inc., a Delaware corporation ("iPCS Hold Co"), iPCS Wireless, Inc., a Delaware corporation ("iPCS Operating Co") and iPCS Equipment, Inc., a Delaware corporation ("iPCS Equipment Co").
W I T N E S S E T H
WHEREAS, Parent acquired iPCS Hold Co in a reorganization in which iPCS Hold Co merged with a wholly-owned subsidiary of Parent with iPCS Hold Co being the survivor of such merger;
WHEREAS, the indenture evidencing Parent's 13 1/2% Senior Subordinated Discount Notes require that iPCS be operated as an "unrestricted subsidiary";
WHEREAS, iPCS and AirGate each possess, or may possess, Technology and Intellectual Property; and
WHEREAS, to facilitate the continued operation of each others' business, the parties desire to provide for a license to the others under its Technology and Intellectual Property for use in conducting its business;
NOW, THEREFORE, in consideration of the foregoing and the mutual agreements and covenants hereinafter set forth, the parties hereby agree as follows:
ARTICLE I
DEFINITIONS
Each capitalized term used herein shall be defined as follows:
"AirGate" shall mean Parent, ASC, AGWL, ANS and any other Person at the time it becomes a Subsidiary of Parent (other than iPCS Hold Co and its existing or future Subsidiaries).
"Affiliate(s)" shall mean, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, such first Person. A Person shall be deemed to control another Person if such first Person possesses, directly or indirectly, the power to direct or cause the direction of the management and policies of such other Person, whether through the ownership of voting securities, by contract or otherwise.
"Date of This Technology License Agreement" shall mean January 1, 2002.
"Intellectual Property" shall mean all patents, and patent applications, disclosures of inventions, trademarks, trademark applications, copyrights, copyright applications to the extent
{PAGE}
owned by, or licensed to (with a right to transfer such license royalty-free) AirGate or iPCS, as of the Date of this Technology License Agreement or invented, discovered or otherwise acquired during the term of this Technology License Agreement.
"iPCS" shall mean iPCS Hold Co, iPCS Operating Co, iPCS Equipment Co and any other Person at the time it becomes a Subsidiary of iPCS Hold Co.
"Person" shall mean an individual, corporation, partnership, limited liability company, trust of unincorporated organization, a government or any agency or political subdivision thereof.
"Subsidiary(ies)" of any Person shall mean any corporation, partnership or other Person of which a majority of all the outstanding capital stock (including directors' qualifying shares) or other securities or ownership interests having ordinary voting power to elect a majority of the board of directors or other Persons performing similar functions is, at the time as of which any such determination is being made, directly or indirectly owned by such Person, or by one or more of the Subsidiaries of such Person, and which Person is consolidated with such Person for financial reporting purposes.
"Technology" shall mean trade secrets, research and development information, research and technology reports and files, formulations, manufacturing and environmental procedures and drawings of plants, equipment and apparatus, analytical methods and laboratory procedures, raw material and product specifications, operating manuals, pilot plant information, library materials, software, databases and computer programs, financial, accounting, management, information technology, human resources, and other business systems and practices, improvements, formulae, practices, processes, methods and other know-how, whether or not patentable, to the extent owned by, or licensed to (with a right to transfer such license royalty-free) AirGate or iPCS, as of the Date of this Technology License Agreement or invented, discovered or otherwise acquired during the term of this Technology License Agreement.
ARTICLE II
LICENSE GRANT
2.1 Each party hereby grants to each other party a royalty-free, fully paid-up, worldwide, non-exclusive license (i) to make, use, and sell any product, (ii) to use any process or method, including but not limited to databases and software, (iii) to practice any invention, whether or not patentable, and (iv) to use any trademark or copyrighted material for any business purpose, such rights and license being with respect to any Technology and Intellectual Property owned by the licensing party as of the Date of This Technology License Agreement and/or invented, discovered or otherwise acquired during the term of this Technology License Agreement.
2.2 No party shall have the right to sublicense and/or otherwise transfer any rights granted herein to any Person.
2.3 In the event that any party makes any improvement to the Technology and/or Intellectual Property, the other parties are granted hereby a royalty-free, fully paid-up, worldwide, non-exclusive license (i) to make, use, and sell any product, (ii) to use any process or method, including but not limited to databases and software, (iii) to practice any invention, whether or not patentable, and (iv) to
2
{PAGE}
use any trademark or copyrighted material for any business purpose, such rights and license being with respect such improvement.
2.4 All the rights and licenses granted hereunder by each party are free from any royalty or payment of any kind.
2.5 Except as noted otherwise herein, no party is obligated hereunder to provide any personnel to aid in the use of the Technology and Intellectual Property licensed herein.
339753
|
AirGate PCS
As referenced in this Technology License Agreement:
AirGate PCS, Inc – PAGE}
Exhibit 10.35
-------------
TECHNOLOGY LICENSE AGREEMENT
TECHNOLOGY LICENSE AGREEMENT (this "Technology License Agreement"), dated
as of January 1, 2002, by and among AirGate PCS, Inc ., a Delaware corporation
("Parent"), AirGate Service Company, Inc., a Delaware corporation ("ASC"), AGW
Leasing Company, Inc., a Delaware corporation ("AGWL"), AirGate Network
_____________
AirGate PCS, Inc – delivery service, by confirmed facsimile transmission,
or by registered or certified mail, postage prepaid, return
receipt requested, addressed as follows:
If to iPCS: AirGate PCS, Inc .
233 Peachtree Street, N.E.
Harris Tower, Suite 1700
Atlanta, Georgia 30303
Attention: General Counsel
If to AirGate: AirGate PCS, Inc.
233 _____________
AirGate PCS, Inc – to iPCS: AirGate PCS, Inc.
233 Peachtree Street, N.E.
Harris Tower, Suite 1700
Atlanta, Georgia 30303
Attention: General Counsel
If to AirGate: AirGate PCS, Inc .
233 Peachtree Street, N.E.
Harris Tower, Suite 1700
Atlanta, Georgia 30303
Attention: General Counsel
or to such other address as any _____________
AIRGATE PCS, INC – IN WITNESS WHEREOF, the parties hereto have caused this Technology License
Agreement to be duly executed as of the date first written above.
AIRGATE PCS, INC .
By: ____________________________________________
Thomas M. Dougherty, President and Chief
Executive Officer
AIRGATE SERVICE COMPANY, INC.
By: ____________________________________________
Thomas M. Dougherty, President and Chief
_____________
dt 690312
| |
Preview
Full Doc
 | 2002 |
Technology License Agreement
Technology License Agreement (62K)
Doc #994361: Click preview link for longer preview.
<TEXT>
3
TECHNOLOGY LICENSE AGREEMENT
by and between
PATH 1 NETWORK TECHNOLOGIES INC.
("Licensor")
and
VISIONARY SOLUTIONS, INC.
("Licensee")
Dated as of December 11, 2001
TABLE OF CONTENTS
1. . . .
994361
| | |
Preview
Full Doc
 | 2002 |
Technology License Agreement
Technology License Agreement (16K)
Doc #1562356: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
THIS AGREEMENT made the 13th day of March, 2002.
BETWEEN:
Dr. Vyacheslav Sova, an individual whose address is 4425 Issaquah-Pine Lake Road, SE, Suite P1, Sammamish, WA, 98075
(the "Licensor")
AND:
GOLDEN CAVIAR CORP., a Nevada corporation whose address is 938 Howe Street, Suite 811, Vancouver, B.C. V6Z 1N9
(the "Licensee")
WHEREAS:
1. Recitals
1.1 Licensor is the owner of certain technology related to the production of caviar and similar goods, as further particularized in Schedule "A", including the technology disclosed in the Russian patents listed . . .
1562356
| | |
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (28K)
Doc #142338: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
BETWEEN POINTDX AND VITAL IMAGES
This Technology License Agreement (Agreement) is effective as of July 13, 2001. The Agreement is made and between PointDX, Inc. a Delaware corporation located in Winston-Salem, North Carolina (PDx), and Vital Images, Inc., a Minnesota corporation located in Plymouth, Minnesota (VTAL).
1. PURPOSE OF THIS AGREEMENT. PDx is exclusive licensee with the right to sublicense certain Patents (as defined below) in the field of virtual endoscopy generally and more specifically, in the field of three-dimensional (3D) visualization of hollow viscus organs. PDx has the right to grant the rights licensed herein under those Patents. VTAL seeks to obtain those licenses.
2. DEFINITIONS.
A. Vitrea Product refers to any volume rendering software with 3D imaging capability. References to Vitrea Product are understood to refer to and encompass VTALs past Vitrea software products, current Vitrea products, and any future modified, enhanced, improved or successor Vitrea products.
B. Patents means the patents and applications therefor listed in Exhibit A hereto, any foreign counterparts thereto, whether now or hereafter issued, any divisions, continuations, and continuations-in-part based on any thereof, any patents which may issue therefrom, and any reissues or extensions on any thereof.
C. CT means computed tomography.
D. CT Endoscopy Application means a software application, whether integrated into and licensed as a part of a Vitrea Product, or licensed as an option to a Vitrea Product, permitting when used in conjunction with a Vitrea Product CT virtual endoscopy.
E. Rex-related features means the technology and inventions for reporting digital radiology images by correlating the radiologists findings with the image data, it being agreed, however, that functions and features contained in any of VTALs past or current Vitrea Products, as well as any substantially similar functions and features contained in any future Vitrea Product, shall not be deemed a Rex-related feature.
F. Lesion Detection and Lymph Node features means the technology and inventions disclosed in the Patents for computer-assisted lesion detection technology or for lymph node targeting.
G. VC Appliance means any Vitrea Product the principal functionality of which is limited to CT virtual colonoscopy.
3. GRANT OF RIGHTS. PDx grants VTAL a perpetual, non-exclusive license to make, have made, use and grant sublicenses or otherwise distribute (itself or through one or more sub-distributors), but only to a person or entity then holding or simultaneously receiving a license to a Vitrea Product, any inventions, whether methods, apparatus or otherwise, disclosed in the Patents, which license shall be retroactively effective with respect to a Patent from the date of issue of such Patent. VTAL acknowledges and agrees that this license does not cover any rights to Lesion Detection and Lymph Node features or to REX-related features. PDx and VTAL agree, however, that they will negotiate in good faith in the future in an effort to reach agreement on a license on substantially equivalent terms to those then outstanding if VTAL should request access to any Lesion Detection and Lymph Node features or to REX-related features.
The parties agree and acknowledge that all intellectual property of either PDx or VTAL, existing as of the date of this Agreement,shall remain the sole property of that party. The only rights granted in or to any of PDxs intellectual property are those granted by this Agreement.
4. PAYMENTS AND ROYALTIES. In consideration for the rights granted in this Agreement, VTAL shall pay PDx the following sums in the following manner.
142338
|
Vital Images
As referenced in this Technology License Agreement:
Vital Images, Inc. – Technology License Agreement (Agreement) is effective as of July 13, 2001. The Agreement is made and between PointDX, Inc. a Delaware corporation located in Winston-Salem, North Carolina (PDx), and Vital Images, Inc. , a Minnesota corporation located in Plymouth, Minnesota (VTAL).
1. PURPOSE OF THIS AGREEMENT. PDx is exclusive licensee with the right to sublicense certain Patents (as defined below) in the _____________
Vital Images, Inc. – those hereinabove contained. This Agreement cannot be modified except by a separate written agreement signed by both parties (or their representatives) to this Agreement
/s/ Albert Emola
Albert Emola
President
Vital Images, Inc.
/s/ David J. Vining, M.D.
David J. Vining, M.D.
Chief Executive Officer
PointDX, Inc.
EXHIBIT A
1. United States Patent No. 5,782,762, issued on July _____________
Vital Images, Inc. – EXHIBIT B
FOR IMMEDIATE RELEASE
VITAL IMAGES SIGNS TECHNOLOGY LICENSE AGREEMENT WITH POINTDx
Technology Supports Vital Images CT Colonography Application
for Early Detection of Colon Cancer
Minneapolis, July XX, 2001 Vital Images, Inc. (Nasdaq SmallCap: VTAL), a medical imaging software company, has signed an agreement with PointDx, Inc. to license from PointDx patents related to virtual endoscopy, a technique that uses software _____________
Vital Images, Inc. – will revolutionize radiologys quality-of-service for healthcare providers, hospitals, and patients. More information about PointDx and REX can be found at the companys web site (www.pointdx.com).
About Vital Images, Inc.
Vital Images is a leading provider of 3D imaging software for use in disease screening applications, clinical diagnosis and therapy planning. The company's technology utilizes high-speed volume _____________
Vital Images Inc. – on Form 10-K for the year ended December 31, 2000 and most recent Form 10-Q for the quarter ended March 31, 2001.
# # #
Vitrea is a registered trademark of Vital Images Inc.
_____________
dt 1330918
;
| PointDX, Inc.
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (77K)
Doc #142339: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT ------------------------------------
This Technology License Agreement ("Agreement") is made as of this 29th day of June, 1990 by and between WEITEK Corporation, a corporation with a principal place of business at 1060 Arques Avenue, Sunnyvale, California 94086 ("WEITEK") and MIPS Computer Systems, Inc., a California corporation with a principal place of business at 950 de Gulgne Drive, Sunnyvale, California 94086 ("MIPS"). WEITEK and MIPS are sometimes referred to singly as "party" and collectively as the "parties."
1. DEFINITIONS
The following terms shall have the following meanings for purposes of this Agreement:
1.1 ASP - means the average selling price during the fiscal quarter for which compensation is being computed. The ASP shall be computed by dividing the Net Revenue received by WEITEK from the sale of each type of MIPS Chip (on a component basis) or Modified MIPS Chip (on a component basis) by the total number of each type of MIPS Chip or Modified MIPS Chip thereof sold during the applicable fiscal quarter.
1.2 DESIGNATED PROCESS TECHNOLOGY - means any technology for the design and manufacture of integrated circuit products that incorporates a type of circuit structure containing both p-channel and n-channel MOS devices on the same silicon substrate (CMOS OR Bi-CMOS).
1.3 EFFECTIVE DATE - means the date first above written.
1.4 GENERATION - means a MIPS Architecture and its Lineal Descendants, a MIPS Chip and its Lineal Descendants and/or a WEITEK Chip and its Lineal Descendants, all in the same Designated Process Technology.
1.5 INTERNAL USE - means the use of a product (whether hardware, software or combination thereof) to perform its intended and customary function by and for the benefit of the party using the product and not for sale, distribution or sublicensing to others. Internal Use includes, but is not limited to, evaluation, development, maintenance, customer support, employee training and the like.
1.6 LINEAL DESCENDANT - means changes and/or modifications within the same Process Technology of MIPS Architecture, MIPS Chip, or WEITEK Chip containing common design parameters and substantially similar functions and/or capabilities. Such changes and/or modifications includes as examples, without limitation, whether singly or in combination, such items as changes to improve manufacturability, process yield, or reliability, changes to fix functional design errors, and changes of speed and/or pin-out.
1.7 MIPS - means MIPS Computer Systems, Inc., a California corporation and each of its subsidiaries which, except for MIPS Computer Systems, Inc., 50% or more of the voting stock or controlling equity is directly owned by MIPS Computer Systems, Inc., or 100% of the voting stock or controlling equity interest of which is directly owned by a corporation which is itself at least 50% or more owned by MIPS Computer Systems, Inc.
1.8 MIPS-BASED SYSTEM - means a computer system containing a CPU which employs MIPS Architecture and/or MIPS Instruction Set.
1.9 MIPS ARCHITECTURE - means the organization, structure, and content of any CPU or CPU support chips, or portions thereof, as designed and enhanced by MIPS, including but not limited to, MIPS Instruction Set (for example, the architecture set forth in the book entitled, MIPS RISC ARCHITECTURE) and interface specifications.
1.10 MIPS CHIP(S) - mean(s) (a) the CPU product(s) designed and/or modified by or on behalf of MIPS; (b) the CO-processor product(s) designed and/or modified by or on behalf of MIPS to connect with and operate with the CPU'S; and (c) any other integrated circuit product(s) designed, developed, and/or acquired by MIPS during the Term of this Agreement which (i) is offered by MIPS for sale on a component basis to third parties in the ordinary course of business or (ii) is offered to other MIPS architecture licensees for manufacture and sale on a component basis to third parties in the ordinary course of business. Notwithstanding the foregoing, nothing in this definition shall require MIPS, or be deemed to create an obligation on the part of MIPS, to create, develop, or acquire any particular MIPS Chip referred to above. MIPS Chips do not include those custom MIPS Chips designed by or on behalf of MIPS exclusively for a third party.
1.11 MIPS COMMERCIAL DOCUMENTATION - means the manuals, user guides, and other documentation relating to MIPS Architecture, MIPS Chips, MIPS Commercial Software or MIPS Systems, as applicable, including all modifications, Patches, New Releases, Updates, derivations of and any other changes thereto, whether in written, graphical, human readable or machine-readable form, and on any medium, when MIPS offers for sale or distribution to third parties in the ordinary course of business, as set forth in MIPS then current price list or similar publication.
1.12 MIPS COMMERCIAL SOFTWARE - means the software in both source code form and object code form owned, licensed or otherwise acquired by MIPS as of the Effective Date or thereafter during the Term including all modifications, Patches, New Releases, Updates, derivations of and any other changes thereto, whether in written, graphical, human readable, machine-executable or machine-readable form, and on any medium, which MIPS offers for licensing by third parties in the ordinary course of business, as set forth in MIPS then current price list or similar publication. MIPS Commercial Software includes MIPS Binary Software and MIPS Source Code Software.
1.13 MIPS DOCUMENTATION - means MIPS Commercial Documentation and MIPS Architecture License Documentation.
1.14 MIPS INSTRUCTION SET - means all or a portion of MIPS instruction set as implemented in MIPS Chips, as applicable (for example, the instruction set specified in the book entitled "MIPS RISC ARCHITECTURE").
1.15 MIPS ARCHITECTURE LICENSE DOCUMENTATION - means the manuals, user guides and other documentation relative to the MIPS Architecture, MIPS Chips or MIPS Software, as applicable, including all modifications, Patches, New Releases, Updates, derivations of and other changes thereto, whether in written graphical, human readable or machine readable form, and on any medium, which MIPS makes available to architecture licensees, which is not set forth in MIPS then current price list or similar publication and which is provided by MIPS to WEITEK for any of the activities contemplated to be performed by WEITEK pursuant to this Agreement.
142339
|
MIPS Tech
As referenced in this Technology License Agreement:
MIPS Technologies, Inc – and entered into as of
the 19th day of June, 1996 (the "Effective Date") between Weitek Corporation, a
California corporation ("Weitek"), and Quantum Effect Design, Inc. ("Quantum").
WHEREAS, Weitek and MIPS Technologies, Inc . ("MIPS") are parties to
that certain Technology License Agreement dated as of June 29, 1990 (the
"License Agreement"); and
WHEREAS, Weitek desires to assign the License Agreement to Quantum, _____________
MIPS Technologies, Inc – Thomas J. Riordan
Title: President Title: President
AMENDMENT No. 1 TO THE
TECHNOLOGY LICENSE AGREEMENT
This Amendment No. 1 to the Technology License Agreement (this "Amendment")
is entered into between MIPS Technologies, Inc . ("MIPS") and Quantum Effect
Design, Inc. ("QED"), effective March 31, 1997.
WHEREAS, MIPS Computer Systems, Inc. ("MCSI") and Weitek Corporation ("Weitek")
entered into a Technology License Agreement, dated June _____________
dt 1365092
;
Silicon Graphics
As referenced in this Technology License Agreement:
Silicon Graphics, Inc – License Agreement, dated June 19, 1990 (the "Weitek
Technology License Agreement"), under which MCSI licensed to Weitek certain
technology, including the MIPS(R) Instruction Set Architecture;
WHEREAS, MCSI merged into Silicon Graphics, Inc . ("SGI") effective on June 29,
1992, and MIPS, as the surviving business entity to MCSI, succeeded to the
rights and obligations of MCSI under the Weitek Technology License Agreement;
_____________
dt 1549597
;
WEITEK Corporation;
| MIPS Computer Systems, Inc.;
Pmc Sierra Inc
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (40K)
Doc #142343: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT*
This Technology License Agreement is entered into as of December 22, 2000 ("Effective Date") between MystiCom Limited ("MystiCom") an Israeli corporation with a principal place of business at 6 Ha'zoran Street, Netanya 42504 Israel and Virata Ltd. ("Licensee"), an English corporation with a principal place of business at Mount Pleasant House, 2 Mount Pleasant, Huntingdon Road, Cambridge CB3 OBL England.
A. MystiCom is developing and has developed certain proprietary implementations of hardware designs and related technology.
B. Licensee wishes to obtain a license from MystiCom to manufacture and distribute products that incorporate certain of MystiCom's technology.
In consideration of the mutual promises, covenants and conditions contained herein the parties agree as follows:
1. DEFINITIONS
When used in this Agreement, the following terms have the following meanings:
1.1 Affiliate means an entity that directly or indirectly controls, --------- is controlled by, or is under common control with Licensee, for as long as such control exists, provided that each Affiliate exercising rights under this Agreement agrees in writing to be bound by the terms of this Agreement. For purposes of this definition, "control" means the ownership of more than fifty percent of the voting stock of such entity, or if such entity is not a corporation, the ability to control the day-to-day operations and business of such entity.
1.2 Confidential Information means any confidential or proprietary ------------------------ information, source code, software tools, designs, schematics, plans or any other information relating to any research project, work in process, future development, scientific, engineering, manufacturing, marketing or business plan or financial or personnel matter relating to either party, its present or future products, sales, suppliers, customers, employees, investors or business, identified and marked by the disclosing party as Confidential Information, whether in oral, written, graphic or electronic form. If disclosed orally, to be accorded status as Confidential Information such information must be identified as confidential or proprietary at the time of disclosure, reduced to writing thereafter marked as confidential and delivered to be receiving party within thirty (30) days following initial disclosure.
1.3 Core means the MystiCom hardware designs identified in Exhibit A, ---- including without limitation (a) any part or component thereof and (b) any improvements, Updates, or other modifications supplied by MystiCom under this Agreement.
1.4 Deliverables means the items MystiCom will deliver to Licensee, ------------ as described in Exhibit B.
1.5 Device means a semiconductor device or other product of Licensee ------ incorporating one or more Instantiations.
1.6 Documentation means the documentation specified on Exhibit A or ------------- supplied by MystiCom in conjunction with the Core.
------------------------ * Portions of the material in this Exhibit have been redacted pursuant to a request for confidential treatment, and the redacted material has been filed separately with the Securities and Exchange Commission (the "Commission"). An asterisk has been placed in the precise places in this Agreement where we have redacted information, and the asterisk is keyed to a legend which states that the material has been omitted pursuant to a request for confidential treatment.
1
{PAGE}
1.7 Error means a material nonconformity of the Core with the ----- Specifications.
1.8 Instantiation means the embodiment or incorporation of the Core ------------- in one instance in a semiconductor device or other product. If the Core is embodied or incorporated in a semiconductor device or other product in more than one instance, each time the Core is embodied or incorporated in such semiconductor device or other product will be considered a separate Instantiation.
1.9 Intellectual Property Rights means all current and future trade ---------------------------- secrets, copyrights, patents and other patent rights, trademark rights, service mark rights, mask work rights and any and all other intellectual property or proprietary rights now known or hereafter recognized in any jurisdiction in any and all media.
1.10 Specifications means the specifications for the Core, as more -------------- fully described in Exhibit A.
1.11 Taxes mean all taxes, levies, imposts, duties or other charges of ----- whatsoever nature however imposed by any subdivision or authority of or in that country in any way connected with this Agreement or any instrument or agreement required hereunder plus all interest, penalties or similar liabilities with respect thereto, except such taxes as are imposed on or measured by MystiCom's net income by a country, or any subdivision or authority of or in that country, in which MystiCom is doing business for purposes of that country's income tax laws.
1.12 Updates means Error correction, bug fixes, minor modifications, ------- or minor improvements to the Core which are provided to Licensee under this Agreement.
2. GRANT OF RIGHTS
2.1 License Grant. MystiCom grants to Licensee and its Affiliates a ------------- worldwide, non-exclusive, non-transferable, perpetual, royalty bearing license, without right to sublicense, to the Core with full rights to make, have made, use, reproduce, and prepare derivative works solely for the purpose of integrating the Core into the Devices. MystiCom further grants Licensee and its Affiliates a worldwide, non-exclusive, non-transferable license to import, export, sell, offer to sell, and distribute the Devices to third parties including end users, OEMs, and through a multi-tiered distribution network.
2.2 License to Documentation. MystiCom grants to Licensee and its ------------------------ Affiliates a non-exclusive right to copy, modify, and distribute (within and outside of Licensee) the Documentation solely for the purpose of supporting Licensee's customers.
2.3. License Restrictions. Licensee acknowledges that, except as -------------------- stated in Sections 2.1 and 2.2, this Agreement does not grant Licensee any right or license under any proprietary rights of MystiCom and that any usage of the Core not within the scope of the licenses granted in this Agreement is prohibited.
3. DELIVERY AND ACCEPTANCE
3.1 Deliverables. MystiCom will use reasonable commercial efforts to ------------ deliver the Deliverables to Licensee in accordance with the schedule in Exhibit B.
3.2 Acceptance. The Deliverables will be deemed accepted by Licensee ---------- if MystiCom is not notified in writing of any Errors ("Error Report") within thirty (30) days after delivery of each Deliverable to Licensee; provided that the time period will be sixty (60) days for the final Deliverable. In the event that Licensee notifies MystiCom of such Errors, MystiCom will, at its option, repair or replace the Deliverable, as soon as commercially practicable. Prior to submitting an Error Report, Licensee will make reasonable efforts to isolate the Error to a particular file or hardware environment. The Error Report will state with particularity the Error discovered, identify the file in which the Error exists, and identify the hardware and software environment in which Licensee tested the Deliverable. Licensee also will provide MystiCom with access to any hardware and software, not already in MystiCom's possession, which Licensee used to test
142343
| MystiCom Limited;
| Virata Corp
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (26K)
Doc #142345: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
This Technology License Agreement (Agreement) dated as of the Effective Date as defined below is made by and between Silicon Evolution, Inc., an Oregon corporation, ("SEI"), and Isonics Corporation, a California corporation, ("Isonics").
RECITALS
A) SEI owns certain intellectual property assets which are more particularly described on Exhibit "A" (the " SEI IP").
B) SEI has licensed intellectual property from Wacker Siltronic Corporation and Wacker-Siltronic AG by agreement dated May 31, 2000 which are more particularly described on Exhibit "B" (the "Wacker IP").
C) Isonics desires to obtain a license to use, commercialize, and sell products made with the IP, and to further license and sublicense the SEI IP and the Wacker IP.
D) SEI is willing to grant such a license to Isonics on the terms set forth herein.
1. DEFINITIONS
a. AFFILIATE: "Affiliate" of a party shall mean any person, organization, or entity that in any way, directly or indirectly, controls, is controlled by, or is under common control with such party. For the purposes of this definition, "control" shall mean ownership of at least fifty percent (50%) equity interest in or by such person, organization, or entity.
b. BUSINESS: "Business" shall mean the business of manufacturing and marketing silicon-on-insulation wafers for the semiconductor industry.
c. BUSINESS INFORMATION: "Business Information" means any material in human or machine readable form used, compiled or produced by or for the business of manufacturing and using the Licensed Technology for the Licensed Products as set forth on Exhibit "A".
d. CLEAN ROOM LEASES. "Clean Room Leases" means a sublease and two equipment leases, each of which is currently existing (although in default) between SEI and: (i) IMAT, Inc. who is the lessee of Building D (Phase VIII), D-100, located at 12516 N.E. 95th Street, Vancouver, Washington, which granted SEI a sublease for that property on March 1, 2000, but has served a notice of termination of that sublease effective October 7, 2001; (ii) IMAT, Inc. who is the owner of a DI water system made by US Filter Corporation and who has leased that equipment to SEI pursuant to a lease dated April 1, 2000, which lease is in default and as to which the lessor has served a notice of termination effective October 7, 2001; and (iii) Techno Vest International who is the owner of a Class 10 Cleanroom with related facilities which includes chiller, air-handling unit and air-duct, and a water clean station with related facilities which include waste chemical pump stations and chemical fume exhaust systems, and who has leased that
1 {Page}
equipment to SEI pursuant to a lease dated April 30, 2000, which lease is in default and as to which the lessor has served a notice of termination effective October 7, 2001.
e. CONFIDENTIAL INFORMATION. "Confidential Information" shall mean (i) any patent applications, Trade Secrets, or Know-How held by either party and regardless of whether marked or designated "confidential" or "proprietary," and (ii) any information disclosed to the receiving party orally or in writing or in model form, in whatever format, relative to operations, existing and proposed contracts, sales training and techniques, financial data, trade secrets, marketing and business plans, research and/or development, data, formulae, processes, designs, specifications, product knowledge, procedures, methods and techniques whether disclosed by way of documents, oral communications, or visits to factories or other premises, and all information regarding the existing and proposed commercial operations of the disclosing party or relative to any other confidential proprietary information which is clearly marked at the time of disclosure as being "Confidential." Information transmitted orally and identified at that time as being Confidential shall be considered as "Confidential Information" if it is reduced to writing and transmitted to the receiving party within 15 days of its disclosure. "Confidential Information" does not include information relating to the Licensed Technology that SEI may provide to Isonics, which information Isonics may use and disclose in its discretion.
f. COPYRIGHTS: "Copyright(s)" means all forms of proprietary rights granted by a government with respect to an original work of authorship fixed in any tangible medium of expression from which it can be perceived, reproduced or otherwise communicated relating to the relating to the Technology covered by, and existing at the time of, this Agreement as specifically set forth in Exhibit "A".
g. EFFECTIVE DATE: "Effective Date" means that date when SEI executes and delivers this Agreement to Isonics by facsimile or hand delivery.
h. IMPROVEMENTS: "Improvements" shall mean any enhancement or modification of the Licensed Technology by Isonics.
i. KNOW-HOW: "Know How" means all factual knowledge and information related to the Business and the Technology which is not capable of precise, separate description but which, in accumulated form, after being acquired as a result of trial and error, gives to the one acquiring it the ability to produce and market something which one would otherwise not have known how to produce and market with the same accuracy or precision necessary for commercial success, provided, however, that such knowledge and information is not in the public domain or readily available to any third party other than a limited number of persons who have agreed to keep that information secret.
j. LICENSED PRODUCT: "Licensed Product" shall mean the products manufactured using any of the Licensed Technology.
k. LICENSED TECHNOLOGY: "Licensed Technology" shall mean the SEI IP and the Wacker IP.
l. PARTY: "Party" shall mean either SEI or Isonics as the context requires.
142345
|
Isonics
As referenced in this Technology License Agreement:
Isonics – defined below is made by and between Silicon Evolution, Inc., an Oregon
corporation, ("SEI"), and Isonics Corporation, a California corporation,
("Isonics").
RECITALS
A) SEI owns certain intellectual property assets which are "Isonics" – and between Silicon Evolution, Inc., an Oregon
corporation, ("SEI"), and Isonics Corporation, a California corporation,
("Isonics" ).
RECITALS
A) SEI owns certain intellectual property assets which are more particularly
described on Isonics – May 31, 2000 which are more
particularly described on Exhibit "B" (the "Wacker IP").
C) Isonics desires to obtain a license to use, commercialize, and sell
products made with the IP, Isonics – IP
and the Wacker IP.
D) SEI is willing to grant such a license to Isonics on the terms set forth
herein.
1. DEFINITIONS
a. AFFILIATE: "Affiliate" of a party shall Isonics, – Information" does not include information relating to the Licensed
Technology that SEI may provide to Isonics, which information Isonics may
use and disclose in its discretion.
f. COPYRIGHTS: "Copyright(s)"
dt 21788
;
| Silicon Evolution, Inc.
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (33K)
Doc #142351: Click preview link for longer preview.
Technology License Agreement
This technology license agreement ("Agreement") is entered into this 17th day of May, 2001 and is by and between the following Parties:
Licensor: NRG Tech, Inc. ("Licensor") A Nevada corporation 681 Edison Way Reno, NV 89502 TEL: (775) 857-1937 FAX: (775) 857-1938
Licensee: Chapeau, Inc. ("Licensee") 508 Island Ave. Reno NV 89502
Recitals
A. LICENSOR holds a license interest in certain rights including Technology Rights (as defined below) including the right to grant a sublicense thereof.
B. LICENSEE wishes manufacture and sell certain products in the Licensed Field of Use (as defined below) using the Technology Rights.
C. LICENSOR and LICENSEE have separately entered into a Technology Development Agreement the complete performance of which is a condition precedent to the effectiveness of this Agreement.
D. LICENSOR is willing to permit LICENSEE to manufacture and sell products based on the Technology Rights within the Licensed Field of Use only on the terms and conditions set forth herein and only after complete performance of the terms of the aforementioned Technology Development Agreement.
Terms
NOW, THEREFORE, the Parties agree as follows:
SECTION 1 - DEFINITIONS
1.1 Technology Rights. The following terms shall each have their respective defined meanings:
(a) United States Patent Rights. "United States Patent Rights" shall mean United States Patent Application Serial No. 09/541,541 filed on April 3, 2000, and any and all U.S. patents issuing therefrom.
(b) Foreign Patent Rights. "Foreign Patent Rights" shall mean the claims of any foreign patent application or foreign patent required to exercise the United States Patent Rights.
(c) Patent Rights. "Patent Rights" shall mean United States Patent Rights and Foreign Patent Rights collectively.
(d) Trade Secrets. "Trade Secrets" shall mean all trade secrets, know-how, technology, inventions and information developed during and in connection with the performance of a certain Technology Development Agreement between the Parties as it relates to commercial implementation of certain products under the Patent Rights.
(e) Technology Rights. "Technology Rights" shall mean Patent Rights and Trade Secrets collectively.
(f) Improvements. "Improvements" shall mean all improvements, modifications, changes or enhancements made or developed in relation to (i) any of the Technology Rights or (ii) any product, apparatus, device or component, including a Licensed Product, which utilizes any portion of the Technology Rights.
1.2 Field of Use. "Field of Use" shall mean sub-600kW stationary electrical generation apparatuses powered by a spark- ignited internal-combustion engine, where the mechanisms and apparatuses for steam reformation, exhaust gas recirculation, and fuel control technology have been designed and engineered by LICENSOR, and where such mechanisms and apparatuses are manufactured and operated in strict compliance with LICENSOR'S specifications.
1.3 Licensed Product. "Licensed Product" shall mean any product or process embodying the Technology Rights or a portion thereof, implemented using the Technology Rights or a portion thereof, or falling within the scope of any claim of any patent or patent application of the Patent Rights, all within the Field of Use. Licensed Product shall include both a complete natural gas powered engine according to the Technology Rights and an apparatus for installation on a natural gas powered engine according to the Technology Rights, all within the Field of Use.
1.4 Customer. "Customer" shall be any third party that (i) acquires possession of a Licensed Product from LICENSEE (whether by purchase, rental, lease or otherwise), or (ii) practices a method of the Technology Rights using a Licensed Product.
1.5 Information. During the performance of the terms of this Agreement, LICENSEE will learn highly sensitive, proprietary information in the possession of LICENSOR. The information may include inventions, trade secrets, information concerning or relating to the Technology Rights, designs, patent applications, formulas, processes, recipes, equipment, prototypes, models, materials, mock-ups, samples, materials, manufacturing methods, business plans, marketing information, customer lists, supplier lists, forecasts and the like (collectively "Information").
142351
| NRG Tech, Inc.;
| Chapeau Inc
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (55K)
Doc #142354: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
This Agreement is entered into as of March 28, 2001 (the "Effective Date") by and between ATR Technology, LLC, a limited liability company of the state of Nevada and having its principal place of business at 29 East 31st Street, New York, New York ("ATR") and Sarcor Management, S.A. a British Virgin Islands (BVI) corporation having its principal place of business at Tudor House, Llanvanor Road, London, England NW22AQ("Sarcor").
WHEREAS, Sarcor is in the business of developing, using, and licensing others to use and is the owner of, or has the relevant licenses to use, certain human resource compiler based search recognition software and hardware ("Sarcor Technology"); and
WHEREAS, ATR is in the business of technology, consulting, and recruitment solutions and personnel and services ("ATR Products"); and
WHEREAS, ATR desires to license the Sarcor Technology for use in conjunction with the ATR Products;
NOW THEREFORE, for good and valuable consideration and on the promises and premises set forth below, the parties agree as follows:
1. DEFINITIONS.
1.1 CONFIDENTIAL INFORMATION:
a. SARCOR CONFIDENTIAL INFORMATION: Confidential and/or proprietary information relating to the Search Technology, research, development, products, processes, trade secrets, business plans, customers, finances, and personnel data related to the business of Sarcor. Sarcor Confidential Information does not include any information (i) which ATR knew before Sarcor disclosed it to ATR; (ii) which has become publicly known through no wrongful act of ATR; (iii) which ATR developed
/1/
independently, as evidenced by appropriate documentation; (iv) which is disclosed to ATR by a third party without restriction of confidentiality; or (v) the disclosure of which is required by law.
b. ATR CONFIDENTIAL INFORMATION: Confidential and/or proprietary information relating to the research, development, products, processes, trade secrets, business plans, customers, finances, and personnel data related to the business of ATR. ATR Confidential Information does not include any information (i) which Sarcor knew before ATR disclosed it to Sarcor; (ii) which has become publicly known through no wrongful act of Sarcor; (iii) which Sarcor developed independently, as evidenced by appropriate documentation; (iv) which is disclosed to Sarcor by a third party without restriction of confidentiality; or (v) the disclosure of which is required by law.
1.2 DERIVATIVES: Any or all translation (including translation into other human or computer languages), portation, modification, correction, addition, extension, upgrade, update, enhancement, revision, new version, improvement, compilation, abridgement, or other form in which the Intellectual Property Rights may be recast, transformed, or adapted, including any products, systems or other items which provide comparable or enhanced functionality whether or not specifically based on or derived from such Intellectual Property Rights.
1.3 SARCOR DOCUMENTATION: Any and all manuals, user guides, product specifications and other documentation, owned by or licensed to Sarcor, relating or referring to the Sarcor Technology.
1.4 SARCOR RIGHTS: Any and all Intellectual Property Rights and Derivatives, of Sarcor in and to the Sarcor Copyrights, Sarcor Documentation, Sarcor Marks, Sarcor Patents, Sarcor Technology and/or the Project Work Product.
142354
| ATR Technology, LLC;
Sarcor Management, S.A.;
| Caredecision Corp
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (33K)
Doc #142357: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
THIS TECHNOLOGY LICENSE AGREEMENT (the "Agreement"), is entered into as of June 1, 2001 (the "Effective Date"), by and between BASF-LYNX BIOSCIENCE AG, a corporation established under the laws of Germany, with its principal place of business at Heidelberg, Germany (the "Joint Venture"), and LYNX THERAPEUTICS, INC., a Delaware corporation, with its principal place of business at Hayward, California ("Lynx").
RECITALS
WHEREAS, Lynx and BASF AG have formed, through wholly-owned subsidiaries, the Joint Venture to conduct a research program in the areas of neurological diseases, toxico-pharmacology, and the development of production strains of microorganisms for fermentations;
WHEREAS, the Joint Venture has been conducting its research program using Lynx Licensed Technology under the Technology License and Development Agreement dated January 1, 1997, as amended by the First Amendment to Technology License and Development Agreement of October 23, 1998, between BASF Biotechnologies Beteiligungs-und Verwertungsgesellschaft mbH and Lynx Therapeutics GmbH (the "Old License Agreement"); and
WHEREAS, the parties desire to terminate the Old License Agreement and enter into this Agreement upon the Effective Date in accordance with the terms and conditions hereinafter stated.
NOW, THEREFORE, Lynx and the Joint Venture hereby agree as follows:
1. DEFINITIONS
1.1 "BEADS" shall mean the combitag beads that have covalently attached to their surface oligonucleotide polymers of at least [...***...] bases, which beads are useful in the conduct of MPSS and Megasort analyses.
1.2 "NEUROSCIENCE FIELD" shall mean the diagnosis, treatment or prevention of neurological diseases associated with the loss or structural alterations of neurons or glial cells, including epilepsy, Alzheimer`s Disease, Parkinson`s Disease, stroke, head trauma, multiple sclerosis, dystonia and Lou Gehrig`s Disease and other motorneuron diseases.
1.3 "INSTRUMENT IMPROVEMENTS" shall mean all modifications and improvements to the MPSS equipment that are made by or on behalf of Lynx and incorporated in the then current standard model of such MPSS equipment for production or commercial use during the term of this Agreement.
1.4 "JOINT VENTURE INVENTIONS" shall mean any invention, discovery, development, concept, or idea, whether or not patentable or copyrightable, that is made by or on behalf of the Joint Venture (including by any of its employees, agents, contractors or collaborators) during the term of
______________________ *CONFIDENTIAL TREATMENT REQUESTED
1. {PAGE} 2
the Agreement, and including without limitation processes, methods, software, formulae, data, techniques, compositions of matter, and devices, and all improvements thereof and know-how and trade secrets relating thereto.
1.5 "LYNX LICENSED TECHNOLOGY" shall mean Lynx's proprietary technologies for conducting MPSS and Megasort analyses, as existing on the Effective Date and as improved by Lynx during the term of this Agreement, including but not limited to the Lynx Patents and the Lynx Know-How and the Lynx Bioinformatics.
1.6 "LYNX BIOINFORMATICS" shall mean the software and other proprietary means owned or controlled by Lynx during the term of the Agreement that is useful for analyzing data obtained through the application of Lynx Licensed Technology.
1.7 "MASSIVELY PARALLEL SIGNATURE SEQUENCING" or "MPSS" shall mean the technology owned and/or controlled by Lynx for simultaneously generating signature sequences of cDNAs in a Megaclone(TM) Library disposed in a flow cell using the ligation-based sequencing method described in Brenner et al. Nature Biotechnology, 18: 630-634 (2000).
1.8 "LYNX KNOW-HOW" shall mean the information, data, knowledge, methods, procedures, processes, and techniques owned or controlled by Lynx (a) that comprise the method of performing Megasort analyses, (b) that comprise the MPSS method or that are directly related to using the MPSS Instruments in conducting MPSS analyses, or (c) that comprise the Lynx Bioinformatics. The term "Lynx Know-How" shall not include any information or trade secrets relating to the manufacture of the Beads or other proprietary Reagents and which are not necessary to know in order to perform MPSS or Megasort analyses using Reagents supplied by Lynx.
1.9 "MEGASORT" shall mean Lynx's methodology for detecting and isolating cDNA molecules that are differentially expressed in two samples using fluorescence activated cell sorting.
1.10 "MPSS INSTRUMENT" shall mean the equipment, designed and developed by Lynx, that can conduct MPSS analyses of templates sampled from a given cell culture or tissue cDNA library, and all Instrument Improvements to such equipment made or acquired by Lynx during the term of the Agreement.
1.11 "LYNX PATENTS" shall mean (a) any and all U.S. and corresponding foreign patent applications, whether now existing or hereafter filed, that are owned or controlled by Lynx and that claim MPSS Instruments, Reagents and/or Lynx Bioinformatics, or the use thereof, or the methods of MPSS or Megasort, and (b) any divisions, continuations, continuations-in-part, reissues or substitute applications arising from, and based upon, any of the foregoing patent applications, and (c) any patent(s) issuing from any of the foregoing, and including all reexaminations, reissues or extensions of such patents.
1.12 "REAGENTS" shall mean the Beads and such other proprietary reagents, diluents, or materials that are necessary for operating the MPSS Instruments and conducting MPSS or Megasort analyses of template samples, to the extent that such materials are not reasonably available for purchase on the open market.
1.13 "RESEARCH PROGRAM" shall mean the research and drug discovery program to be conducted by the Joint Venture directed to the areas of: (a) discovering novel drug targets and
142357
|
BASF
As referenced in this Technology License Agreement:
BASF- – Agreement"), is entered into as of
June 1, 2001 (the "Effective Date"), by and between BASF- LYNX BIOSCIENCE AG, a
corporation established under the laws of Germany, with its principal place BASF – corporation, with its principal place of business at Hayward,
California ("Lynx").
RECITALS
WHEREAS, Lynx and BASF AG have formed, through wholly-owned subsidiaries,
the Joint Venture to conduct a research program BASF – by the First Amendment to Technology License
and Development Agreement of October 23, 1998, between BASF Biotechnologies
Beteiligungs-und Verwertungsgesellschaft mbH and Lynx Therapeutics GmbH (the
"Old License Agreement"); and
WHEREAS, BASF – or practice the Lynx Licensed Technology, to provide
analysis services for any third party, including BASF AG and/or any of its
affiliates. For purposes of clarity, it is understood and BASF- – 94545
USA
Attn: President
Fax: (510) 670-9302
In the case of the Joint Venture: BASF- LYNX Bioscience AG
Im Neuenheimer Feld 515
69120 Heidelberg, Germany
______________________
*CONFIDENTIAL TREATMENT REQUESTED
8.
{
dt 21412
;
|
Lynx
As referenced in this Technology License Agreement:
LYNX THERAPEUTICS, – BIOSCIENCE AG, a
corporation established under the laws of Germany, with its principal place of
business at Heidelberg, Germany (the "Joint Venture"), and LYNX THERAPEUTICS,
INC., a Delaware corporation, with its principal place of business at Hayward,
California ("Lynx").
RECITALS
WHEREAS, Lynx and BASF AG have formed, _____________
Lynx Therapeutics – amended by the First Amendment to Technology License
and Development Agreement of October 23, 1998, between BASF Biotechnologies
Beteiligungs-und Verwertungsgesellschaft mbH and Lynx Therapeutics GmbH (the
"Old License Agreement"); and
WHEREAS, the parties desire to terminate the Old License Agreement and
enter into this Agreement upon the _____________
Lynx Therapeutics, – or to
such other address as either party shall designate by written notice given to
the other party:
In the case of Lynx: Lynx Therapeutics, Inc.
25861 Industrial Boulevard
Hayward, CA 94545
USA
Attn: President
Fax: (510) 670-9302
In the case of the Joint Venture: BASF- _____________
LYNX THERAPEUTICS – thereby.
IN WITNESS WHEREOF, Lynx and the Joint Venture have executed this
Agreement, in triplicate originals but collectively evidencing only a single
contract.
LYNX THERAPEUTICS INC.
By: /s/ Edward C. Albini
----------------------------------------------
Edward C. Albini
Title: Chief Financial Officer
-------------------------------------------
BASF-LYNX BIOSCIENCE AG
By: /s/ Dr. Alfred Bach
----------------------------------------------
Dr. _____________
dt 186672
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (30K)
Doc #142366: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
--------------------------------------------------------------------------------
THIS TECHNOLOGY LICENSE AGREEMENT made and entered into at Austin, Texas, effective this 30th day of April, 2001, by and between Direct Wireless Corporation, a corporation organized under the laws of the State of Texas with its principal place business at 106 E. 6th Street, Suite 650, Austin, Texas 78701 (hereafter referred to as "Licensor") and the Direct Wireless Communications, Inc., a Texas corporation with its principal place of business at 106 E. 6th Street, Suite 645, Austin, Texas 78701 (hereafter referred to as "Licensee").
WHEREAS, LICENSOR is the owner of all right, title and interest in and to certain wireless communications technology more fully described herein (hereafter the Technology), and
WHEREAS, LICENSOR intends to further develop the Technology, including (but not be limited to) additions, modifications and enhancements of the Technology, trade secrets, know-how, technical information and expertise, and
WHEREAS, LICENSEE desires to license directly from LICENSOR the Technology in and for the continental United States.
NOW, THEREFORE, for and in consideration of the faithful performance of the covenants, and obligations contained herein by the parties hereto, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties, intending to be legally bound, agree as follows:
ARTICLE 1 General Definitions and Relationships among Definitions -------------------------------------------------------
The terms contained in this Agreement shall have the meaning set forth in this Article 1.
1.01 LICENSOR and LICENSEE are hereunder commonly referred to as "parties" (in singular and plural usage, as required by the context).
1.02 LICENSED TECHNOLOGY shall mean and include all licensed KNOW-HOW, TRADE SECRETS, LICENSED PATENTS, PATENT RIGHTS, IMPROVEMENTS, LICENSED PRODUCTS, LICENSED COMMUNICATIONS PROTOCOLS AND LICENSED METHODS.
1.03 KNOW-HOW shall mean the engineering, design, and operational techniques possessed by LICENSOR relating to the engineering specifications, manufacture, and operational performance of the LICENSED TECHNOLOGY, which are applicable within the LICENSED FIELD.
E-2
{PAGE}
1.04 LICENSED FIELD shall mean the field of wireless communication systems, wireless communication products, wireless communications protocols and wireless communication methods.
1.05 LICENSED PATENTS means PATENTS and PATENT RIGHTS which relate to inventions in or applicable to the LICENSED PRODUCT OR LICENSED METHOD within the LICENSED FIELD and which are owned or controlled by LICENSOR during the term of this Agreement, or in respect to which LICENSOR has or may acquire during the term of this Agreement the right to grant licenses of the scope to be granted in this Agreement.
1.06 PATENT RIGHTS shall mean U. S. Patent No 5,995,849, filed November 26, 1997 and granted on November 30, 1999, U.S. Patent No. 6,141,531, filed April 17, 1998 and granted on October 31, 2000, U.S. Patent Application No. 800416 filed on June 1, 2000, International Application No. PCT/US98/13972, filed July 6, and any applications on inventions or IMPROVEMENTS based upon the LICENSED TECHNOLGY as well as any related application(s), more specifically, any continuation, divisional, continuation-in-part of substitution applications, and any foreign or domestic applications, corresponding to or based in whole or in part, on any of the above within the LICENSED FIELD.
1.07 IMPROVEMENTS shall mean improvements to and/or of LICENSED TECHNOLOGY, whether or not patentable, which during the continuance of this Agreement are made, conceived or acquired by either party or to which either party obtains rights which it can provide to the other without obligation to third parties, including changes made for the purpose of improving the operation, efficiency, manufacturability or deployment of the LICENSED PRODUCT or LICENSED METHOD within the LICENSED FIELD.
1.08 LICENSED PRODUCT shall mean any and all products which employ or are produced by the practice of inventions claimed in the LICENSED PATENTS or by the LICENSED TECHNOLOGY or any and all products that are used to carry out the LICENSED METHOD including but not limited to fixed base units known as Network Extenders and mobile units (also known as transmitter, transceivers, receivers or wireless handsets), repeaters (also known as signal extenders), wireless communications operational protocols, batteries, battery recharge units, specialized antennae, firmware and software.
142366
| Direct Wireless Corporation;
| Direct Wireless Communications Inc
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (23K)
Doc #142368: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
This Technology License Agreement (the "Agreement") is entered into as of May 31, 2001 (the "Effective Date"), by and between Menta Software Ltd., a corporation organized under the laws of Israel with an office at 13 Gush Etzion Street, ___ Givat Shmuel, ___ 54030, Israel ("Company"), ___ and GraphOn Corporation, a Delaware corporation, with an office at 400 Cochrane Circle, Morgan Hill, CA 95037 USA ("Licensee").
RECITALS
WHEREAS, Company has expended considerable time, effort and resources in the development of certain proprietary software; and
WHEREAS, Licensee desires to obtain an exclusive license to the proprietary software on the terms and conditions contained herein.
NOW THEREFORE, in consideration of the mutual promises contained herein, the parties agree to the following:
1. Definitions. The following terms shall have the following meanings.
1.1 ___ "Company Software" means the proprietary software as described in Exhibit A, as it exists on the Effective Date together with all add-ons, supplements, bug fixes, new versions, updates, and the like which Company is obliged to or does deliver to Licensee under this Agreement. Company Software includes and shall be delivered in both in commented Source Code and Object Code form, together with all Documentation.
1.2 ___ "Confidential Information" means (i) the Company Software; (ii) any enhancements, modifications and derivative works of or to the Company Software, made by Company or Licensee; (iii) the terms and conditions of this Agreement; and (iv) all non-public information provided by one party to the other under this Agreement that is identified as proprietary or confidential.
1.3 ___ "Intellectual Property Rights" means all worldwide copyright, trademark, trade secret, and all rights related to issued and pending patents, and all copyright, ___ trademark and patent ___ registrations ___ and applications for registrations ___ (including ___ patent reissues, ___ divisions, continuations, continuations-in-part, renewals and extensions) in or related to the Company Software.
1.4 ___ "Documentation" means all user manuals, comments on source code, schematics, and other documents as may exist that pertain to the use, performance, capabilities and compatibility, installation, maintenance, or development (coding) of the Company Software.
1.5 ___ "Development ___ Tools" ___ means all software ___ tools, ___ libraries, proprietary development environments, APIs, and other software necessary or convenient to the development of derivative works of the Company Software, or the maintenance and improvement of the Company Software, which are under the control of Company.
1.6 ___ "Deliverables" means all things, including the Company Software, and Documentation, that Company is obliged to deliver to Licensee under this Agreement.
1.7 ___ "Exclusivity Period" mans a period of time commencing on the Effective Date and lasting one year.
142368
| Menta Software Ltd.;
| Graphon Corp/de
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (59K)
Doc #142370: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
THIS TECHNOLOGY LICENSE AGREEMENT (this "License Agreement"), dated this 17th day of August, 2000 ("Effective Date"), is made by and between ADLABS, INC., a corporation organized under the laws of the State of California ("ADLABS"), and SUMMUS, LTD., a corporation organized under the laws of the state of Delaware ("SUMMUS"). ADLABS and SUMMUS are sometimes individually referred to as "Party" and collectively as "Parties".
R E C I T A L S
A. SUMMUS owns or possesses rights to proprietary wavelet technology, software and documentation, that, among other things, enhances the degree of compression of digital images without pixelization distortion and enables pattern recognition; and
B. ADLABS is in the business of developing and marketing a broad range of products and services for the medical industry, including the operation of centralized regional anatomic pathology laboratories providing hospitals, pathologists and other physicians with advanced digital imaging, database systems and other technologies to enhance the process of tissue processing and the diagnosing, tracking and treating of disease; and
C. SUMMUS has agreed to grant to ADLABS, on the terms and conditions set forth in this License Agreement, certain rights and licenses to SUMMUS' proprietary technology, software, documentation, improvements and marks, including any related patents now or hereafter issued, and the right to grant certain sublicenses; and
D. ADLABS desires to engage SUMMUS to perform services from time to time to assist ADLABS in carrying out its business objectives in a series of project phases. The Parties acknowledge that SUMMUS owns the Core Technology, that ADLABS has requested that SUMMUS modify the Core Technology for ADLABS' Business in the Field, that certain of such modifications (defined below as "Core Technology Improvements") will improve the Core Technology generally, while others (defined below as "ADLABS Improvements") will improve the Core Technology specifically for performance in the Field, and that the Parties intend for ADLABS to have exclusive rights to use the ADLABS Improvements.
NOW THEREFORE, in consideration of the foregoing and the mutual premises set forth in this License Agreement, the Parties agree as follows:
1. DEFINITIONS.
1.1 "ADLABS Improvements" shall mean any and all changes or modifications to the SUMMUS Code implementing Functional Specifications or {PAGE} 2 Joint Functional Specifications, and including directly related Work Product, but only to the extent such changes or modifications are specifically for performance in the Field and are identified as ADLabs Improvements in the Work Statements executed in connection with the Master Agreement.
1.2 "ADLABS Patents" means any patents now or hereafter issued, assigned, licensed or sublicensed to ADLABS with respect to the ADLABS Technology.
1.3 "ADLABS Technology" shall mean ADLABS' technologies described in Exhibit "B" attached hereto together with (a) the Functional Specifications and/or the Joint Functional Specifications, (b) any technology hereafter acquired or developed by or for ADLABS relating to the Field and disclosed in writing to SUMMUS or identified in a Work Statement, and (c) including directly related Work Product, certain aspects of which may be covered by the patents now or hereafter issued (United States or foreign) or in pending patent applications.
1.4 "Affiliated Entity" means any corporation, partnership or other entity that is in or under the direct or indirect control of ADLABS, and for such purpose "control" shall exist whenever ADLABS, or the persons who own ADLABS, owns voting securities or similar interests representing at least 80% of the total of such interests of the pertinent entity then outstanding.
1.5 "Business" shall mean ADLABS' business in the Field as described in the recitals above.
1.6 "Core Technology" shall mean SUMMUS' technologies described in Exhibit "A" attached hereto, technologies identified as Core Technology in Work Statements, and directly related Work Product, certain aspects of which may be covered by the copyrights or patents now or hereafter issued (United States or foreign) or in pending patent applications.
1.7 "Core Technology Improvements" shall mean any and all changes or modifications to the SUMMUS Code implementing Functional Specifications or Joint Functional Specifications, as the same may be identified in Work Statements, and directly related Work Product, but only to the extent such changes or modifications represent general improvements to the Core Technology rather than ADLABS Improvements.
1.8 "Field" shall mean any and all aspects of the medical diagnosis of disease at the cellular level in humans in the area of anatomic pathology.
1.9 "Final Royalty" shall mean an ongoing royalty payable after the Phase II Acceptance Date equal to four percent (4%) of the gross revenue generated
142370
|
Pennie & Edmonds
As referenced in this Technology License Agreement:
Pennie & Edmonds
– copy to:
Jennifer L. Collins, Esq. Rory J. Radding, Esq.
Womble Carlyle Sandridge & Rice, PLLC Pennie & Edmonds
150 Fayetteville Street Mall, Suite 2100 1155 Avenue of the Americas
Raleigh, NC 27602
dt 32974
;
Womble Carlyle
As referenced in this Technology License Agreement:
Womble Carlyle – a copy to: With a copy to:
Jennifer L. Collins, Esq. Rory J. Radding, Esq.
Womble Carlyle Sandridge & Rice, PLLC Pennie & Edmonds
150 Fayetteville Street Mall, Suite 2100 1155 Avenue of
dt 32358
;
Adlabs, Inc.;
| Summus, Ltd.;
Summus Inc Usa
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (183K)
Doc #142372: Click preview link for longer preview.
This TECHNOLOGY LICENSE AGREEMENT (the "Agreement") is made the 23rd day of April 2001 (the "Effective Date")
BETWEEN
ARM LIMITED, whose registered office is situated at 110 Fulbourn Road, Cambridge CB1 9NJ England ("ARM")
and
MARVELL INTERNATIONAL LIMITED whose registered office is situated at Richmond House, 3rd Floor, 12 Par-la-Ville Road, P.O. Box HM 1022, Hamilton HK DX Bermuda ("LICENSEE")
ARM and LICENSEE are each also a "party" hereunder and collectively are the "parties" hereunder.
WHEREAS
ARM is the owner of certain Intellectual Property, Intellectual Property Derivatives, and the know-how to manufacture the ARM946E-S Core, ARM966E-S Core and ETM9 Macrocell as such terms are defined below.
LICENSEE has requested ARM, and ARM has agreed, to license LICENSEE to manufacture and distribute ARM Compliant Products as defined herein and thereby to make use of certain portions of the Intellectual Property and Intellectual Property Derivatives as set forth in this Agreement.
Therefore, in consideration of the mutual representations, warranties, covenants, and other terms and conditions contained herein, the parties agree as follows:
1. Definitions
1.1 "ARM CORE" shall mean either or both as the context admits of; (i) the ARM946E-S Core; and (ii) the ARM966E-S Core.
1.2 "ARM946E-S CORE" shall mean the core as described and identified in the ARM946E-S Core Technical Reference Manual: DDI-0155 as set forth in Schedule 1, Section 2, Part A of this Agreement.
1.3 "ARM946E-S CORE TRANSFER MATERIALS" shall mean that technical information with respect to the ARM946E-S Core as set forth in Schedule 1, Section 2 of this Agreement, and subject to the payment of the Core and Macrocell Maintenance Fees (as defined in Clause 8.3) any Updates thereto.
1.4 "ARM966E-S CORE" shall mean the ARM966E-S Core as described and identified in the ARM datasheet numbered ARM DDI 0164.
1.5 "ARM966E-S CORE TRANSFER MATERIALS" shall mean that technical information with respect to the ARM966E-S Core as set forth in Schedule 1, Section 3 of this Agreement and subject to the payment of the Core and Macrocell Maintenance Fees (as defined in Clause 8.3) any Updates thereto.
1.6 "ARM COMPLIANT PRODUCT" or "ACP" shall mean any single silicon chip developed by LICENSEE or a Subsidiary (subject to Section 2.4), provided that such single silicon chip:
(i) contains a Microarchitecture Compliant Core licensed from ARM; and
(ii) contains additional LICENSEE circuitry, which adds significant functionality.
1.7 "ARMV5TE INSTRUCTION SETS" shall mean the instruction sets as are described and identified in the ARM Architecture Reference Manual: ARM DDI-0100E and such Updates thereto as ARM may from time to time release.
The confidential portions of this agreement omitted pursuant to a confidential treatment request filed separately with the Securities and Exchange Commission and are indicated by the symbol "***"
Page 1 {PAGE} 2
23rd April 2001 CONFIDENTIAL LEX-TLA-1951-G
1.8 "AUTHORIZED DISTRIBUTOR" shall mean those distributors, resellers, or sales representatives appointed, in writing, by LICENSEE.
1.9 "AVERAGE SALE PRICE" or "ASP" shall mean the average price per unit received by LICENSEE for a particular ARM Compliant Product calculated by taking the invoice price charged at arm's length negotiation terms by LICENSEE or any Subsidiary in the sale or distribution of any ARM Compliant Product (excluding Test Chips defined in Section 3 and excluding returned products), less any (i) value added, turnover, import, or other tax, duty, or tariff payable thereon and (ii) freight and insurance costs incurred (in so far as such value added, turnover, import, or other tax, duty, tariff, freight and insurance costs are charged in the sale of such ARM Compliant Products).
1.10 "AVS" shall mean; (i) for the ARM946E-S Core, the ARM Architectural Validation Suite in binary code format identified in Schedule 1, Section 2, Part H Item H1 of this Agreement; and (ii) for the ARM966E-S Core the ARM Architectural Validation Suite in binary code format identified in Schedule 1 Section 3 Part H item H1.
1.11 "CLAIMS" shall mean a written demand received by ARM from the attorneys for, and on the behalf of, a relevant third party demanding that ARM cease and desist from any identified, alleged Intellectual Property infringement.
1.12 "CONFIDENTIAL INFORMATION" shall mean: (i) any trade secrets relating to the ARM946E-S Core, the ARM966E-S Core, the ETM9 Macrocell, the MultiICE, the Transfer Materials and the Software designated in writing by either party, by appropriate legend, as confidential; (ii) any information designated in writing by either party, by appropriate legend, as confidential; (iii) any information which is first disclosed verbally but designated as confidential at the time of disclosure and is thereafter reduced to writing for confirmation and sent to the other party within thirty (30) days after its oral disclosure and designated, by appropriate legend, as confidential; and (iv) the terms and conditions of this Agreement.
1.13 "ETM9 MACROCELL" shall mean the ARM9TDMI Embedded Trace Macrocell, as described and identified in the ETM Specification: IHI 0014 as set forth in Schedule 1, Section 4, Part A Item A1 of this Agreement.
1.14 "ETM9 TRANSFER MATERIALS" shall mean the ARM9TDMI Embedded Trace Macrocell Transfer Materials, as identified in Schedule 1, Section 4 of this Agreement.
1.15 "END USER LICENSE" shall mean a license agreement substantially conforming to that agreement set forth in Schedule 7 of this Agreement.
1.16 "FUNCTIONAL TEST VECTORS" shall mean; (i) with respect to the ARM946E-S Core the test vectors identified in Schedule 1, Section 2, Part D, Items D1 and D2 of this Agreement; and (ii) with respect to the ARM966E-S Core the test vectors identified in Schedule 1, Section 3, Part D, Items D1 and D2.
1.17 "HARVARD ARCHITECTURE" shall mean a microprocessor architecture in which the instruction stream for the integer unit has a separate port from the data stream for such integer unit.
1.18 "INTELLECTUAL PROPERTY" shall mean any patents, patent rights, trade marks, service marks, registered designs, topography or semiconductor maskwork rights, applications for any of the foregoing, copyright, know-how, unregistered design right, trade secrets and know-how, any Intellectual Property Derivatives, and any other similar protected rights in any country.
1.19 "ARM INTELLECTUAL PROPERTY" shall mean any Intellectual Property which are taken into use in the design, use or production of the ARM Core, the ETM9 Macrocell, the MultiICE, the Transfer Materials, or Software.
1.20 "INTELLECTUAL PROPERTY DERIVATIVES" shall mean derivatives of the Intellectual Property, which term shall include: (i) for copyrightable or copyrighted material, any translation, abridgement, revision or other form in which an existing work may be recast, transformed or adapted; (ii) for work protected by topography or mask right, any translation, abridgement, revision or other form in which an existing work may be recast, transformed or adapted; (iii) for patentable or patented material, any improvement; and (iv) for material protected by trade secret, any new material derived from or employing such existing trade secret.
142372
| ARM Limited;
Marvell International Limited;
| Marvell Technology Group Ltd
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (48K)
Doc #142373: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
THIS TECHNOLOGY LICENSE AGREEMENT (the "Agreement") is made and entered into as of March 28, 2001 (the "Effective Date"), by an among Inktomi Corporation, a Delaware corporation, with its principal place of business at 4100 East Third Avenue, Foster City, CA 94404 ("Licensor"), and e-centives, Inc., a Delaware corporation, with its principal place of business at 6901 Rockledge Drive, 7th Floor, Bethesda, MD 20817 ("Licensee").
WHEREAS, the Licensee and the Licensor are parties to that certain Asset Purchase Agreement dated as of January 18, 2001 (the "Purchase Agreement"), pursuant to which Licensor has agreed to sell to Licensee certain software and other assets related to Licensee's Commerce Product Business (as defined in the Purchase Agreement), and to license to Licensee the source code of Licensor's search solutions technology and related materials that are actively used in both the Commerce Product Business and Licensee's other business;
WHEREAS, Licensor is duly qualified and authorized to grant such license(s) and to provide related maintenance services and Licensee desires to obtain such a license and receive such maintenance services; and
WHEREAS, it is a condition to closing the Purchase Agreement that Licensor enter into this Agreement.
NOW, THEREFORE, in consideration of the mutual promises and obligations set forth herein, the parties hereto agree as follows:
1 DEFINITIONS
When used herein with initial capitalizations, whether in the singular or in the plural, the following terms shall have the following meanings:
"Commerce Engine" means that software and related technology and documentation assigned to Licensee by Licensor pursuant to the Purchase Agreement, including any future enhancements, modifications, and upgrades made by Licensee to the Commerce Engine. Commerce Engine does not include the Software or the Zeta Software.
"Commerce Product Software" means a software program or programs, that is licensed and/or distributed externally as a licensed software product that primarily provides commerce functionality or are primarily related to commerce. Commerce Product Software includes Rockslide.
"Documentation" means all written materials (to the extent such written materials exist) relating to the Licensee's use, installation or operation of the Search Solutions Software, the IDP Proxy Software, and the Zeta Software in connection with the Commerce Products Business or any Modification, Enhancement or Update to either of the foregoing provided in accordance with this Agreement, including, but not limited to, the application program interface and other materials identified in Exhibit A, and any user manuals and documentation; training manuals, documentation and lesson plans; program specifications; and materials; file layouts and data models; design documents and specifications and any other materials prepared in connection with any software Modification, Enhancement or Update; any materials pertaining to the features, use, functioning and operation of the software; implementation plans
{PAGE} 2
***** Confidential Treatment has been requested for portions of this agreement. The copy filed herewith omits information subject to the confidential treatment request. Omissions are designated as [*****]. A complete version of this agreement has been filed separately with the Securities and Exchange Commission.
and other documentation developed in connection with software installation planning and acceptance or other test plans and documentation. Documentation does not include: (i) any code of (a) the Search Solutions Software, (b) the IDP Proxy Software, (c) the Zeta Software, or any (d) Modification, Enhancement or Update to either of the foregoing; or (ii) the IDP.
"Enhancements" means any program, any part thereof, or any materials that improves, adds to, or expands the capabilities and functionality of the Licensed Technology. Enhancements do not include Modifications or Upgrades.
"IDP" means the Inktomi Data Protocol that is utilized to communicate with the Software, the specification for which is referenced on Exhibit A.
"IDP Proxy Software" means Licensor's IDP proxy technology software that is utilized in the Commerce Product Business as of the Effective Date, in both source code and executable code format, identified on Exhibit A, and all Enhancements or Upgrades thereto.
"Intellectual Property" or "Intellectual Property Rights" has the meaning set forth in the Purchase Agreement.
"Licensed Technology" means the Search Solutions Software, the IDP Proxy Software, the Zeta Software, IDP, and the Documentation.
"Maintenance and Support Services" means the full complement of tasks and activities which Licensor is required to provide under Section 8 of this Agreement with respect to the Licensed Technology.
"Modification" means those additions, changes, and modifications to the functionality of the Licensed Technology which have been requested by the Licensee and which will be provided by the Licensor under this Agreement. "Modifications" do not include error corrections, bug fixes, patches, updates, revised versions, new releases, Enhancements or Upgrades to the Licensed Technology.
"Rockslide" means the productized version of the Commerce Engine which would be licensed and/or distributed externally as a licensed software product.
"Search Solutions Software" means Licensor's search solutions technology software that is utilized in the Commerce Product Business as of the Effective Date, in both source code and executable code format, identified on Exhibit A, and all Enhancements or Upgrades thereto.
"Software" means the IDP Proxy Software and the Search Solutions Software.
"Upgrades" means improvements, error corrections, bug fixes and/or patches in the Licensed Technology which relate to operating performance, but do not change the basic function of the Licensed Technology. Upgrades do not include Modifications or Enhancements.
"Zeta Software" means Licensor's reporting solutions technology software utilized as part of the Commerce Product Business as of the Effective Date, in both source and executable code format identified on Exhibit A, and all Enhancements or Upgrades thereto.
142373
| Inktomi Corporation;
| E Centives Inc
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (38K)
Doc #142374: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
THIS TECHNOLOGY LICENSE AGREEMENT, including the Exhibits ("Agreement"), effective as of 23 April 2001 ("Effective Date"), is hereby made by and between Imaginon, Inc., a Delaware corporation, having principal offices at 1313 Laurel Street, San Carlos, California 94070 ("Licensor") and Wireless Web Data, Inc., a Delaware corporation, having principal offices at 1313 Laurel Street, Suite 4, San Carlos, California 94070 ("Licensee").
RECITALS
A. Licensor is in the business of developing Licensed Technology, which is embodied in hardware and/or software for narrowband networks, broadband networks, and interactive computer-based applications.
B. Licensor has developed an Internet search engine ("WebZinger"), a proof of concept of a search agent ("Vizario"), and the engineering specifications for Vizario for use in its interactive video application, "ImaginVideo, also known as "ImOn.comTV", more specifically described in Exhibit ------- A attached hereto and incorporated herein by reference. -
C. Licensee desires to obtain an exclusive license the wireless device and wireless Internet applications of WebZinger and Vizario as set forth below and Licensor desires to grant such license on the terms and conditions set forth below
AGREEMENT
For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
1. DEFINITIONS -----------
1.1 "Documentation" shall mean written materials or graphic files that ------------- are displayed or printed and that relate to and support the Licensed Technology.
1.2 "Licensed Product" shall mean any product developed and licensed or ---------------- sold which incorporates the Licensed Technology or any part thereof. Licensed Technology
41 {PAGE} 1.3 "Licensed Technology" shall mean Licensor's proprietary WebZinger ---------------------- and Vizario software, technology, Documentation and intellectual property including but not limited to patents, copyrights, trade secrets and other intellectual property rights related to WebZinger and Vizario. The Licensed Technology does not include any upgrades, new versions or releases, enhancements or updates to the Licensed Technology developed by Licensor, unless agreed to by the Licensor at its sole discretion.
2. OWNERSHIP; GRANT OF RIGHTS -----------------------------
2.1 Ownership. Licensor shall own all right, title, and interest in --------- the Licensed Technology, Licensee shall own all right, title and interest in any modifications, improvements or enhancements to the Licensed Technology made or conceived by Licensee.
2.2 License Grant. Licensor hereby grants Licensee an exclusive, world-wide, ------------- perpetual right and license, subject to the limitations contained herein, to use, reproduce, distribute directly and indirectly, modify and make derivative works of the Licensed Technology for wireless device and wireless Internet applications other than the Internet television applications pursued by Licensor.
2.3 Documentation. Licensor agrees to provide Licensee copies of the ------------- Documentation in a mutually agreed upon electronic format.
2.4 Delivery of Masters. Pursuant to the license set forth above, --------------------- Licensor shall provide Licensee two sets of masters for WebZinger, the Vizario Engineering Specification and the Vizario Proof of Concept. The masters shall be in machine readable, binary form and will include WebZinger, the Vizario Proof of Concept and the Documentation. The masters shall be shipped to Licensee within five (5) business days after the execution of this Agreement or as otherwise agreed by the parties.
3. RESTRICTIONS ON LICENSEE --------------------------
3.1 End User Restriction. Licensee shall, and shall require its ---------------------- distributors and resellers to, include an end user license with each copy of the Licensed Product distributed to an end user. Licensee agrees to promptly notify Licensor of any breach of the end user license with respect to the Licensed Product, and further agrees that it will vigilantly pursue any third parties in breach of such license.
3.2 No Reverse Engineering. Licensee shall not reverse assemble, ------------------------ de-compile, or reverse engineer the Licensed Technology or any part thereof except as specifically authorized in writing by Licensor.
3.3 Licensing to U.S. Government. Licensee shall not market, sell or ------------------------------ otherwise convey the Licensed Technology to the United States Government or any foreign government without Licensor's prior written consent. If Licensor provides such consent, Licensee shall identify or mark any copies of the Licensed Technology and Documentation provided pursuant to any agreement with the United States Government or any contractor therefor, as follows: (i) For acquisition by or on behalf of civilian agencies, as necessary to obtain protection substantially equivalent to that afforded to restricted computer Licensed Technology and related documentation developed at private expenses no part of which was developed with government funds and provided with Restricted Rights in accordance with subparagraphs (a) through (d) of the "Commercial Computer Licensed Technology - Restricted Rights" clause at 48 C.F.R. 52.227-19 of the Federal Acquisition Regulations and its successors; or (ii) for acquisition by or on behalf of units of the Department of Defense ("DOD") as necessary to obtain protection substantially equivalent to that afforded to commercial computer Licensed Technology and related documentation developed at private expenses and provided with Restricted Rights as defined in DOD FAR Supplement 48 C.F.R. 52.227-7013(c)(1)(ii) and its successors.
142374
|
ImaginOn
As referenced in this Technology License Agreement:
Imaginon, Inc. – txt
{TEXT}
EXHIBIT 10.1
TECHNOLOGY LICENSE AGREEMENT
THIS TECHNOLOGY LICENSE AGREEMENT, including the Exhibits ("Agreement"),
effective as of 23 April 2001 ("Effective Date"), is hereby made by and between
Imaginon, Inc. , a Delaware corporation, having principal offices at 1313 Laurel
Street, San Carlos, California 94070 ("Licensor") and Wireless Web Data, Inc., a
Delaware corporation, having principal offices at 1313 Laurel _____________
Imaginon, Inc. – shall be followed by written notification via
courier service or U.S. Mail.
13.2 Addresses. The addresses for notification under this Agreement are:
----------
David M. Schwartz James A. Newcomb
Imaginon, Inc. Wireless Web Data, Inc.
1313 Laurel Street 1313 Laurel Street, Suite 4
San Carlos, CA 94070 San Carlos, CA 94070
Telephone: 650-596-9300 Telephone: 650-596-9066
Facsimile: _____________
IMAGINON, INC. – 650-596-7390
IN WITNESS WHEREOF, the parties hereto have executed this Agreement by
persons duly authorized as of the date and year first above written.
48
{PAGE}
LICENSOR: LICENSEE:
IMAGINON, INC. WIRELESS WEB DATA, INC.
By: /s/ David M. Schwartz By: /s/ James A. Newcomb
-------------------------- --------------------------
Name: David M. Schwartz Name: James A. Newcomb
Title: Chief Executive Officer Title: Chief Executive _____________
dt 1469327
;
Wireless Web Data, Inc.;
| Vizario Inc
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (27K)
Doc #142375: Click preview link for longer preview.
THIS TECHNOLOGY LICENSE AGREEMENT made and entered into at Austin, Texas, effective this 30th day of April, 2001, by and between Direct Wireless Corporation, a corporation organized under the laws of the State of Texas with its principal place business at 106 E. 6th Street, Suite 650, Austin, Texas 78701 (hereafter referred to as "Licensor") and the Direct Wireless Communications, Inc., a Texas corporation with its principal place of business at 106 E. 6th Street, Suite 645, Austin, Texas 78701 (hereafter referred to as "Licensee").
WHEREAS, LICENSOR is the owner of all right, title and interest in and to certain wireless communications technology more fully described herein (hereafter the Technology), and
WHEREAS, LICENSOR intends to further develop the Technology, including (but not be limited to) additions, modifications and enhancements of the Technology, trade secrets, know-how, technical information and expertise, and
WHEREAS, LICENSEE desires to license directly from LICENSOR the Technology in and for the continental United States.
NOW, THEREFORE, for and in consideration of the faithful performance of the covenants, and obligations contained herein by the parties hereto, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties, intending to be legally bound, agree as follows:
ARTICLE 1 General Definitions and Relationships among Definitions
The terms contained in this Agreement shall have the meaning set forth in this Article 1.
1.01 LICENSOR and LICENSEE are hereunder commonly referred to as "parties" (in singular and plural usage, as required by the context).
1.02 LICENSED TECHNOLOGY shall mean and include all licensed KNOW-HOW, TRADE SECRETS, LICENSED PATENTS, PATENT RIGHTS, IMPROVEMENTS, LICENSED PRODUCTS, LICENSED COMMUNICATIONS PROTOCOLS AND LICENSED METHODS.
1.03 KNOW-HOW shall mean the engineering, design, and operational techniques possessed by LICENSOR relating to the engineering specifications, manufacture, and operational performance of the LICENSED TECHNOLOGY, which are applicable within the LICENSED FIELD.
1.04 LICENSED FIELD shall mean the field of wireless communication systems, wireless communication products, wireless communications protocols and wireless communication methods.
E-22 {PAGE}
1.05 LICENSED PATENTS means PATENTS and PATENT RIGHTS which relate to inventions in or applicable to the LICENSED PRODUCT OR LICENSED METHOD within the LICENSED FIELD and which are owned or controlled by LICENSOR during the term of this Agreement, or in respect to which LICENSOR has or may acquire during the term of this Agreement the right to grant licenses of the scope to be granted in this Agreement.
1.06 PATENT RIGHTS shall mean U. S. Patent No 5,995,849, filed November 26, 1997 and granted on November 30, 1999, U.S. Patent No. 6,141,531, filed April 17, 1998 and granted on October 31, 2000, U.S. Patent Application No. 800416 filed on June 1, 2000, International Application No. PCT/US98/13972, filed July 6, and any applications on inventions or IMPROVEMENTS based upon the LICENSED TECHNOLGY as well as any related application(s), more specifically, any continuation, divisional, continuation-in-part of substitution applications, and any foreign or domestic applications, corresponding to or based in whole or in part, on any of the above within the LICENSED FIELD.
1.07 IMPROVEMENTS shall mean improvements to and/or of LICENSED TECHNOLOGY, whether or not patentable, which during the continuance of this Agreement are made, conceived or acquired by either party or to which either party obtains rights which it can provide to the other without obligation to third parties, including changes made for the purpose of improving the operation, efficiency, manufacturability or deployment of the LICENSED PRODUCT or LICENSED METHOD within the LICENSED FIELD.
1.08 LICENSED PRODUCT shall mean any and all products which employ or are produced by the practice of inventions claimed in the LICENSED PATENTS or by the LICENSED TECHNOLOGY or any and all products that are used to carry out the LICENSED METHOD including but not limited to fixed base units known as Network Extenders and mobile units (also known as transmitter, transceivers, receivers or wireless handsets), repeaters (also known as signal extenders), wireless communications operational protocols, batteries, battery recharge units, specialized antennae, firmware and software.
1.09 LICENSED METHOD shall mean any method, process or wireless communications operational protocol covered by the LICENSED TECHNOLOGY and includes, but is not limited to, any method process or wireless communications operational protocol covered by a LICENSED PATENT.
1.10 AFFILIATES of LICENSEE shall mean any corporation, partnership, joint venture or other entity that LICENSEE owns or controls, directly or indirectly. 1.11 Designated Territories shall mean the continental United States.
142375
| Direct Wireless Corporation;
| Direct Wireless Communications Inc
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (33K)
Doc #142376: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
The University of Washington, a public institution of higher education having administrative offices in Seattle, Washington 98195 ("UW"), and Digital Recorders, Inc., a for-profit company having a place of business at 4018 Patriot Drive, One Park Center, Suite 100, Research Triangle Park, NC 27709 ("Company") agree as follows:
BACKGROUND 1.1 UW has developed through the efforts of Professor Daniel J. Dailey ("Dr. Dailey"), an employee of UW, and others in the Department of Electrical Engineering certain software, algorithms, and technical information pertaining to transportation information management systems ("Technology").
1.2 UW desires to license, and Company desires to obtain, rights in the Technology to promote commercial investment in developing the Technology and in creating products incorporating the Technology.
DEFINITIONS 2.1 "Agreement" means this Technology License Agreement and any attachments referenced by this Agreement and its attachments.
2.2 "Effective Date" means the date upon which this Agreement is fully executed by both UW and Company.
2.3 "Technology" means the subject matter set forth on Attachment A.
2.4 "Modification" means any work based on or derived from the Technology. Modifications may include, but are not limited to, corrections of software program errors, translations and stylistic restructuring of the Technology, addition or deletion of functions or enhancement of existing functions of the Technology, changes required to integrate the Technology into other applications, preparation of derivative works based on one or more works comprising the Technology, and other adaptations of the Technology.
2.5 "UW Modification" means a Modification prepared by or under the direction of Dr. Dailey or any successor and which makes changes involving access to Technology source code statements.
2.6 "Company Modification" means a Modification prepared by or for Company by other than UW and its personnel, including Dr. Dailey.
2.7 "Licensed Subject Matter" means the Technology, UW Modifications delivered to Company pursuant to this Agreement, and Company Modifications.
2.8 "End User" means a customer of Company that receives and uses Licensed Subject Matter for customer's internal and/or public operations and not for redistribution, relicensing, disclosure, or conveyance of Licensed Subject Matter beyond the operationsand control of said customer.
2.9 "Sublicense" means (a) a license granted by Company to an End User that permits the use of Licensed Subject Matter by the End User for its own internal and/or public operations; (b) a license granted by Company to a distributor or reseller to act on behalf of Company or under contract to Company to convey or sell Company-branded Licensed Subject Matter to End Users under an appropriate End User license consistent with Article 3.1(c).
GRANT 3.1 UW hereby grants to Company, and Company accepts, worldwide non-exclusive licenses, with the right to sublicense to End Users, under the UW's valuable intangible property rights, and providing for a limited time Company with an exclusive commercial position, as follows:
TECHNOLOGY LICENSE AGREEMENT PAGE 1 OF 7 {PAGE}
(a) to install and operate the Technology and UW Modifications for internal research and evaluation purposes on Company owned or controlled servers and workstations;
(b) to create Company Modifications, and to operate Licensed Subject Matter for internal Company purposes, and to install, deploy, and support Licensed Subject Matter for evaluation and operation by two (2) End Users;
(c) to incorporate the Technology and UW Modifications and Company Modifications into commercial products distributed directly or through third party distributors (but carrying Company and not third-party distributor brands and under a Sublicense for distribution or resale) to customers under a Sublicense for End Use;
(d) to use the Identifiers as set forth on Attachment A, provided that Company uses best efforts to avoid any use that would result in the infringement of any valid trademark held by any third party, and further provided that any trademark rights that may arise from Company use of Identifiers shall be owned by UW.
3.2 UW retains title to the Technology and to all UW Modifications delivered to Company under this Agreement. Company shall own Company Modifications, including but not limited to any patent, copyright, and trademark rights thereto, prepared pursuant to this Agreement and developed without the involvement of UW and UW personnel, including Dr. Dailey, provided any such Company Modifications are managed under the terms and conditions of this Agreement as Licensed Subject Matter.
3.3 Company acknowledges that UW is active in the development of the Technology, and Company agrees that UW may prepare UW Modifications substantially similar to Company Modifications, and that UW shall not be constrained other than by this Agreement in UW's management of such UW Modifications.
3.4 Provided Company is in full compliance with this Agreement, UW shall not grant, for a period of thirty (30) months from the Effective Date, additional licenses to the Technology to for-profit commercial entities other than to former and existing for-profit sponsors of research at UW to which UW has obligations to grant non-exclusive licenses to any or all of the Technology. UW shall promptly inform Company of any obligations that come to the attention of UW's Office of the Vice Provost for Intellectual Property and Technology Transfer regarding such commercial licensing of the Technology.
3.5 UW and Company will, at Company's request, negotiate in good faith an extension of the period set forth in Article 3.4, provided that Company (i) has granted Sublicenses to at least five (5) End Users under Section 3.1(c); (ii) there are no unresolved disputes between UW and Company regarding this Agreement or other agreements between UW and Company; and (iii) Company presents a commercialization plan to UW showing Company investment in developing and supporting the Technology and a continued commitment to serve the transportation information services marketplace.
3.6 UW may grant non-exclusive End User licenses to the Technology and UW Modifications to non-profit organizations and to governments providing regional transportation and transportation information services.
DELIVERY 4.1 UW shall provide to Company the Technology within ten (10) days of the Effective Date to
Bill McFarland Digital Recorders, Inc.
142376
|
DRI
As referenced in this Technology License Agreement:
Digital
Recorders, Inc – 10_7.txt
{DESCRIPTION}EXHIBIT 10.7
{TEXT}
{PAGE}
TECHNOLOGY LICENSE AGREEMENT
The University of Washington, a public institution of higher education having
administrative offices in Seattle, Washington 98195 ("UW"), and Digital
Recorders, Inc ., a for-profit company having a place of business at 4018
Patriot Drive, One Park Center, Suite 100, Research Triangle Park, NC 27709
("Company") agree as follows:
BACKGROUND 1. _____________
Digital Recorders, Inc – to governments providing regional transportation and
transportation information services.
DELIVERY 4.1 UW shall provide to Company the Technology within
ten (10) days of the Effective Date to
Bill McFarland
Digital Recorders, Inc .
Technology License Agreement Page 2 of 7
{PAGE}
4018 Patriot Drive, One Park Center, Suite 100
P.O. Box 14068
Research Triangle Park, NC 27709
who shall serve as _____________
Digital Recorders, Inc – shall be
confirmed by prompt delivery of the hardcopy original.
7.2 In the case of Company:
All correspondence regarding this Agreement should be
addressed to Tanya Johnson.
Postal Address: Digital Recorders, Inc .
Address: 4018 Patriot Drive, One Park Center,
Suite 100
PO Box 14068
Research Triangle Park, NC 27709
Facsimile Address: (919) 361-2947
7.3 In the case of UW:
_____________
Digital Recorders, Inc – parties relating to the subject
matter hereof.
[THE REMAINDER OF THIS PAGE HAS BEEN INTENTIONALLY LEFT
BLANK.]
TECHNOLOGY LICENSE AGREEMENT PAGE 6 OF 7
{PAGE}
The University of Washington and Digital Recorders, Inc . have executed this
Agreement by their respective duly authorized representatives on the dates
given below.
DIGITAL RECORDERS, INC. UNIVERSITY OF WASHINGTON
By: By:
------------------------------ ------------------------------
Name: Name:
---------------------------- ----------------------------
Title: Title:
--------------------------- ---------------------------
Date: Date:
---------------------------- ----------------------------
_____________
DIGITAL RECORDERS, INC – LICENSE AGREEMENT PAGE 6 OF 7
{PAGE}
The University of Washington and Digital Recorders, Inc. have executed this
Agreement by their respective duly authorized representatives on the dates
given below.
DIGITAL RECORDERS, INC . UNIVERSITY OF WASHINGTON
By: By:
------------------------------ ------------------------------
Name: Name:
---------------------------- ----------------------------
Title: Title:
--------------------------- ---------------------------
Date: Date:
---------------------------- ----------------------------
CONCURRENCE:
---------------------------------
Daniel J. Dailey
TECHNOLOGY LICENSE AGREEMENT PAGE 7 OF 7
{PAGE}
Technology License Agreement
Attachment A
Technology
_____________
dt 1531858
;
| The University of Washington
|
Preview
Full Doc
 | 2001 |
Technology License Agreement
Technology License Agreement (7K)
Doc #142377: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
THIS TECHNOLOGY LICENSE AGREEMENT (the "Agreement") is entered into and effective as of December 25, 2000 by and between Guardtec, Inc., a Korean corporation ("GTC"), and Com-Guard.com Inc., a Nevada corporation ("CGI") or the "COMPANY".
RECITALS
This Agreement is entered into with reference to and in contemplation of the following facts, circumstances and representations:
1. GTC is the owner of that certain proprietary computer technology which affords security protection to computer hardware and software in microcomputers and which is collectively referred to herein as "GTC FIREWALL."
2. CGI is a private corporation, which presently plans to submit an application for listing on the NASD OTC Bulletin Board.
3. CGI desires to acquire GTC FIREWALL for the licensed use with the Com-Guard product line, pursuant to the terms and conditions as set forth herein in this Agreement.
2. LICENSE OF GTC FIREWALL
2.1 NATURE AND EXTENT OF GTC FIREWALL: The nature of and extent of GTC FIREWALL shall consist of the use of all of the right, title and interest to GTC FIREWALL combined with the Com-Guard product line, including but not limited to all copyrights, trademarks, patents, object codes, limited use of source codes as changed and provided by GTC, enhancements, updates or other modifications and user manuals, and as more specifically set forth and described in the attached Exhibit "A".
2.2 CONSIDERATION FOR PURCHASE OF GTC FIREWALL: In consideration of the purchase of GTC FIREWALL by CGI, CGI agrees to issue to GTC a total of ONE HUNDRED FIFTY THOUSAND (150,000) shares of CGI common stock (the "CGI Shares").
142377
| Guardtec, Inc.;
| com Guard com Inc
|